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ABSTRACT OF DISSERTATION

FORMATION OF THE ETHER BRIDGE IN THE LOLINE ALKALOID
BIOSYNTHETIC PATHWAY

Lolines are specialized metabolites produced by endophytic fungi, such as
Neotyphodium and Epichloë species, that are in symbiotic relationships with cool-season
grasses. Lolines are vital for the survival of the grasses because their insecticidal and
antifeedant properties protect the plant from insect herbivory. Although lolines have
various bioactivities, they do not have any concomitant antimammalian activities.
Lolines have complex structures that are unique among naturally occurring
pyrrolizidine alkaloids. Lolines have four contiguous stereocenters, and they contain an
ether bridge connecting C(2) and C(7) of the pyrrolizidine ring. An ether bridge connecting
bridgehead C atoms is unusual in natural products and leads to interesting questions about
the biosynthesis of lolines in fungal endophytes.
Dr. Pan, who was a graduate student in Dr. Schardl Lab at University of Kentucky,
isolated a novel metabolite, 1-exo-acetamidopyrrolizidine (AcAP). She observed that
AcAP was accumulating in naturally occurring and artificial lolO mutants. I synthesized
an authentic sample of (±)-AcAP and compared it spectroscopically with AcAP isolated
from a lolO mutant to determine the structure and stereochemistry of the natural product. I
was also able to grow crystals of synthetic (±)-AcAP, X-ray analysis of which further
supported our structure assignment.
There were two possible explanations for the fact that a missing or nonfunctional
LolO led to the accumulation of AcAP: that AcAP was the actual substrate of LolO, or that
it was a shunt product derived from the real substrate of LolO, 1-exo-aminopyrrolizidine
(AP), and that was produced only when LolO was not available to oxidize AP. To
distinguish between the two hypotheses, I synthesized 2´,2´,2´,3-[2H4]-AcAP. Dr. Pan used
this material to confirm that AcAP was an intermediate in loline alkaloid biosynthesis, not
a shunt product.
To determine the product of LolO acting on AcAP, Dr. Pan expressed LolO in yeast
(Saccharomyces cerevisiae). When Dr. Pan fed AcAP (synthesized by me) to the modified
organism, it produced NANL, suggesting that LolO catalyzed two C–H activations of
AcAP and the formation of both C–O bonds of the ether bridge in NANL, a highly unusual
transformation. Dr. Chang then cloned, expressed, and purified LolO and incubated it with
(±)-AcAP, 2-oxoglutarate, and O2. He observed the production of NANL, further
confirming the function of LolO. Dr. Chang also observed an intermediate, which we
tentatively identified as 2-hydroxy-AcAP.
In order to determine whether the initial hydroxylation of AcAP catalyzed by LolO
occurred at C(2) or C(7), I prepared (±)-7,7-[2H2]- and (±)-2,2,8-[2H3]-AcAP. When Dr.
Pan measured the rate of LolO-catalyzed hydroxylation of these substrates under
conditions under which only one C–H activation would occur, she observed a very large
kinetic isotope effect when C(2) was deuterated, but not when C(7) was deuterated,
establishing that the initial hydroxylation of AcAP occurred at the C(2) position.

In order to determine the stereochemical course of C–H bond oxidation by LolO at
C(2) and C(7) of AcAP, I synthesized trans- and cis-3-[2H]-Pro and (2S,3R)-3-[2H]- and
(2S,3S)-2,3-[2H2]-Asp. Feeding experiments with these substrates carried out by both Dr.
Pan (Pro) and me (Asp) showed that at both the C(2) and C(7) positions of AcAP, LolO
abstracted the endo H atoms during ether bridge formation.
In summary, feeding experiments with deuterated (±)-AcAP derivatives and its
amino acid precursors have shown that AcAP is an intermediate in loline biosynthesis. We
have shown that LolO catalyzes the four-electron oxidation of AcAP at the endo C(2)
position first and then the endo C(7) position to give NANL.
KEYWORDS: Loline, biosynthesis, pyrrolizidine, LolO, C–H activation
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Chapter 1. Introduction

Aim and scope of this study
As part of a study to establish the intermediates and elucidate the role of LolO
enzyme in the loline alkaloid biosynthetic pathway.
In this report, I describe the isolation of a previously unknown metabolite from
naturally occurring and artificial lolO mutants. To determine the structure and
stereochemistry of this compound, I synthesized an authentic sample of (±)-AcAP,
demonstrated its stereochemistry, and showed its spectroscopic identity with the metabolite
isolated from the endophyte. I describe the synthesis of deuterium-labeled AcAP
isotopologues, which was then used to confirm that AcAP was an intermediate in loline
alkaloid biosynthesis, not a shunt product (Scheme 1.1).

Scheme 1.1. AcAP as an intermediate in loline biosynthesis. Showing incorporation of D
atom in NANL from d4-AcAP.

In this report, I also describe our investigation to determine what is the product of
LolO acting on AcAP. The experiments involved feeding AcAP to yeast that was
genetically modified with LolO and also to cloned, expressed, and purified LolO. Both
experiments resulted in the production of NANL. The feeding to purified LolO revealed a
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new intermediate between AcAP and NANL, which we tentatively identify as hydroxyAcAP (Scheme 1.2).

Scheme 1.2. Presence of hydroxy intermediate produce during the oxidation of AcAP to
NANL by LolO.

In this report, I describe an independent confirmation of the sequence of C–H
activation events. In order to determine whether the initial hydroxylation of AcAP
catalyzed by LolO occurred at C(2) or C(7), I prepared (±)-7,7-[2H2]- and (±)-2,2,8-[2H3]AcAP. Stop-flow kinetics experiments by Dr. Juan Pan with 2,2,8-[2H3]- and 7,7-[2H2]AcAP under single-oxidation conditions revealed a very large kinetic isotope effect in the
former case, but not in the latter, establishing that the initial hydroxylation of AcAP
occurred at the C(2) position. Dr. Juan Pan was able to isolate 2-hydroxy AcAP from
unreacted ACAP and the product NANL. With the help of 1H NMR, 1H-1H COSY and
NOE experiments, I was able to establish the structure and stereochemistry of isolated
compound as 2-endo-2-hydroxy AcAP (Scheme 1.3).
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Scheme 1.3. Initial Hydroxylation of AcAP at C(2) position on endo face.
In this report, I describes the investigation of the stereochemical course of C–H
bond activation by LolO at C(2) and C(7) of AcAP. I synthesized trans- and cis-3-[2H]Pro and (3R)-3-[2H]- and (3S)-2,3-[2H2]-Asp. Feeding experiments with these substrates
carried out by both Dr. Pan (Pro) and me (Asp) showed that at both the C(2) and C(7)
positions of AcAP, LolO abstracted the endo H atoms during ether bridge formation
(Scheme 1.4).

Scheme 1.4. Abstraction of endo H atoms from C(2) and C(7) of AcAP by LolO.
Endophytes and their interaction with host plants
Endophytes are organisms that flourish intercellularly in host plants, with
asymptomatic infections for some parts or all of their life cycle. The host plants usually
provide all of the essential nutrients (such as sucrose, amino acids, etc.,) to endophytes for
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their survival.1 Endophytes are omnipresent across the plant kingdom (trees, plants,
grasses, algae, etc.) and are commonly fungi and bacteria. Endophytes produce a range of
biologically active compounds that may provide survival benefits to the host plants, such
as protection against its natural enemies.2 Some strains of endophytic fungi only produce
biologically active compounds in symbiosis, while others produce in both symbiosis and
culture. The reasons for this dichotomy are still not understood.
There needs to be a balanced interaction between the endophytes and host plants,
and the interaction is usually maintained by the plant defense system. There are generally
two balanced interactions: commensalism and mutualism. In commensalism, endophytes
survive within the host on the nutrient supply, neither harming nor benefiting the host. On
the contrary, mutualism is an interaction in which both of the organisms provide survival
benefits to the other.3 Under certain conditions, the interaction may become parasitic, i.e.,
harmful for the host plant.4

4

Table 1.1. Summary of Epichloë spp. mediated resistances to multiple biotic and abiotic
stresses.
Stress

Endophyte-mediated response

Drought tolerance

Increase root growth; altered stomatal behavior and
osmotic adjustments

Nematode resistance

Reduced nematode reproduction.

Growth responses

Phytohormones

and synthetic growth hormones,

increased phosphorous and mineral uptake, growth
tolerance

to

low

soil pH

or

high aluminum

concentration, nitrogen use efficiency
Interspecific competition

Increased clonal growth and lateral spread; production
of alleochemicals; increased seedling vigor and seed
yield

Disease resistance

Increased, decreased or no effect, depending on the
system.

Insect resistance

Peramine, lolines, ergot alkaloids

Anti-herbivory of

Ergot alkaloids and indole-diterpenes

mammals
Heat or low light intensity

Enhance tolerance.

An increase in host plant resistance by the endophytes toward other enemies
in a mutualistic relationship is called “acquired plant defense.”5 The host acquires
defense against insects, herbivores, and a wide range of environmental conditions,
such as drought and heat. A summary of Epichloë spp. mediated resistances to
multiple biotic and abiotic stresses is given in Table 1.1.6
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Plants cannot protect themselves by moving away from an attack of their foe, nor
are they blessed with immune systems like animals are. To cope with these problems,
plants have developed defenses such as bark, thorns, etc. They also evolved to synthesize
certain compounds or acquire them from an organism with which they have a symbiotic
relationship. These compounds may act as antifeedants or precursors to physical defense
tools. These compounds are called “secondary” or “specialized” metabolites.7
This interaction between endophytes and host plants has been studied for a long
time for its importance to agriculture. Some specialized metabolites produced by
endophytes may cause problems to grazing livestock but can also possess anti-insect
properties. It has been of great interest for the pastoral farming sector to find the endophyte
strains that can synthesize compounds that have anti-insect activity but lack concomitant
antimammalian activity.6
Many types of specialized metabolites are produced by grass-associated
endophytes. They help the grass to cope with numerous stress conditions such as drought,
protection against vertebrates and invertebrates, and survival in poor soil conditions. The
specialized metabolites discussed in this report are alkaloids that are produced by Epichloë
species, which are groups of filamentous fungi that live as grass endophytes. Alkaloids
produced by Epichloë spp. provide many benefits for the host grass. Some specialized
metabolites produced by endophytes are ergovaline, aminopyrrolizidine, pyrolopyrazines,
the indole-diterpenoids, and 11,12-epoxyjanthitrems (Figure 1.1) may be toxic to cattle and
other livestock. The alkaloids are produced by different species of grasses infected with
endophytes, but not every endophyte-grass association produces alkaloids.6 In this
dissertation, I discuss the loline alkaloids that are produced by endophytic fungi of grasses.
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Figure 1.1. Structure of ergovaline, pyrrolopyrazine, and 10-epi-11,12-epoxyjanthitrem.
Loline background
In 1892, Hofmeister recognized an alkaloid with the elemental formula C7H12N2O
and called it temuline.8 In 1955, Yunusov and Akramov isolated a related alkaloid from
the Lolium temulentum (darnel) seeds and named it loline.9 In addition to loline and
temuline, they also isolated other alkaloids, which they named N-acetylloline. In 1960,
Yunusov and Akramov proposed the structure of loline with an exocyclic nitrogen and an
oxygen attached to the same carbon (A) (Figure 1.2).

Figure 1.2. Proposed structure of loline by Yunusov and Akramov in 1960.
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In 1966, they proposed a new structure, N-methyl-1-endo-aminopyrrolizidine (B)
(Figure 1.3).9

Figure 1.3. Revised proposed structure of loline by Yunusov and Akramov in 1966.
In 1965, Yates and Tookey proposed a structure for festucine that was the same as
loline, but the N-methyl group was on the exo face (C) (Figure 1.4).

Figure 1.4. Revised proposed structure of loline by Yates and Tookey in 1965.
In 1969, Aasen and Culvenor showed that the structure of loline was identical to
festucine. In 1972, Bates and Morehead established the absolute configuration of loline
dihydrochloride by X-ray crystallographic analysis. The structure of loline is now regarded
as having a pyrrolizidine nucleus with an ether linkage and containing both endocyclic and
exocyclic nitrogen (C).9 In 1985, Dannhardt and Steindl reported that temuline and
norloline were the same alkaloid.10
Later on, various research groups isolated numerous types of lolines with different
types of substituents (methyl, formyl, acetyl, propionyl, butyryl, isobutyryl, isovaleryl, and
senecioyl) on the amino group. Some of the common lolines are shown in Figure 1.5.9 In
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our work, the most relevant lolines have been norloline (NL), N-acetylnorloline (NANL),
and N-formylloline (NFL). Until now, all evidence has suggested that these alkaloids are
produced by fungal endophytes, not by the host plants.11

Figure 1.5. Various naturally occurring loline alkaloids
Unusual features in loline structure
Lolines have unusual molecular architectures for pyrrolizidine natural products.
They have a tricyclic structure containing at least one heteroatom in every ring, and they
have four contiguous stereocenters. The molecule is strained due to the presence of the
ether bridge, which links two bridgehead C atoms, a very unusual context for a natural
product. All but one of the carbon atoms in the pyrrolizidine ring are attached to a
heteroatom. These features have caused scientists in detail to study the biosynthetic
pathway leading to lolines.
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What have we learned in the past about the biosynthetic pathway of loline?
Working together, our group and Dr. Schardl’s group were able to identify
precursors and intermediates in loline alkaloid biosynthesis by feeding isotopically labeled
substrates to a loline-producing culture of Epicoloë. uncinata and analyzing by GC-MS the
isotopic content of the produced loline alkaloids (Scheme 1.5).12-13 These experiments
showed that L-proline (Pro) and L-homoserine, likely in the form of O-acetylhomoserine
(1),12 were the precursors whose carbon and nitrogen atoms were incorporated into the
pyrrolizidine core, whereas L-methionine contributed the carbon atoms of the N-formyl
and N-methyl substituents.12 The experiments also showed that compounds 2 and AP were
likely intermediates in the biosynthetic pathway.13

Scheme 1.5. Proposed biosynthetic pathway to lolines.
We hypothesize that an enzyme encoded by the lolC gene catalyzes the substitution reaction between Pro and 1.12 LolC’s inferred amino acid sequence suggests
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that is a -type pyridoxal-5´-phosphate (PLP) enzyme that is similar to the O-acetylhomoserine(thiol)-lyase encoded by the cysD gene of Aspergillus nidulans.14-15 Oacetylhomoserine(thiol)-lyase catalyzes the -substitution of O-acetylhomoserine with H2S
in methionine biosynthesis (Scheme 1.6).16,13

Scheme 1.6. Comparison of reactions catalyzed by CysD and LolC.
We hypothesize that the likely FAD-containing monooxygenase encoded by the
lolF gene catalyzes the next step, oxidative decarboxylation of the pyrrolidine ring of 2 to
give iminium ion 3.15 LolF is most closely similar to 1,2-cyclopentanone
monooxygenase.

15, 17

Scheme 1.7. Comparison of reactions catalyzed by cyclopentanone monooxygenase and
LolF.
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We further hypothesize that amino acid 3 undergoes decarboxylation catalyzed by
the PLP enzyme encoded by the lolD gene to give amine 4 (Scheme 1.8).15 LolD’s amino
acid sequence suggests that it is related to ornithine decarboxylase.15-16

Scheme 1.8. Comparison of reaction catalyzed by ornithine decarboxylase and proposed
to be catalyzed by LolD.

We hypothesize that the PLP enzyme encoded by the lolT gene catalyzes
cyclization of 4 to the known intermediate AP (Scheme 1.4).13, 15 LolT’s amino acid
sequence suggests that it is closely related to isopenicillin N epimerase.15, 18

Scheme 1.9. Comparison of reactions catalyzed by isopenicillin N epimerase and proposed
to be catalyzed by LolT.

12

There are several different ways that the ether bridge could be introduced into AP
(Scheme 1.5). Either C(2) or C(7) of AP could be hydroxylated to give intermediate 5 or
6, respectively, and either intermediate 5 or 6 could then undergo cyclization to NL by C–
H activation of C(7) or C(2), respectively, followed by ring closure. Either a single or
multiple enzymes could catalyze the hydroxylation and the cyclization.13 We previously
hypothesized that these steps are catalyzed by the dioxygenase and oxidoreductase encoded
by the lolO and lolE genes.15

Synthesis of pyrrolizidine core
1.6.1. Christine et al. approach
In 2000, Christine et al, published a racemic synthesis of AP.19 They initiated the
synthesis by converting L-Pro to ethyl prolinate (7). N-Alkylation of 7 with ethyl acrylate
formed the diester 8, which underwent Dieckmann cyclization, hydrolysis, and
decarboxylation to produce ketone 9, presumably in racemic form due to epimerization
under the decarboxylation conditions. This compound was converted to oxime 10 and then
subjected to Raney Ni reduction to form two separable diastereomers, (±)-AP and (±)-1epi-AP (Scheme 1.10).
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Scheme 1.10. Christine et al synthesis of (±)-AP.
1.6.2. Giri et al. approach

Scheme 1.11. Giri et al. synthesis of (–)-AP.
In 2004, Giri et al. synthesized (–)-AP starting from prolinal 11.20 They converted
11 to the sulfone 12 using the usual procedure, and reaction of 12 with enolate A formed
amino ester 13 with syn:anti = 10:90. Selective reduction of the ester function in 13 with
NaBH4 and CaCl2 produced alcohol 14. Removal of the Boc group in 14 and formation of
a mesylate, which underwent intramolecular SN2 displacement in situ, resulted in the
formation of bicyclic compound (–)-N-Cbz-AP. Removal of the Cbz group then gave
enantiopure (–)-AP (Scheme 1.11).
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1.6.3. Tang et al. approach
In 2004, Tang et al. synthesized (+)-AP during the total synthesis of the natural
product, (1S,8R)-(+)-absouline.21 Their synthesis began with chemoselective reduction of
15 to give alcohol 16, which was subsequently treated with thiophenol to form sulfide 17.
Nucleophilic reaction by allyl iodide produced 18. Treatment of 18 with BH3·SMe2 and
subsequent oxidation with H2O2 under basic conditions resulted in the formation of alcohol
19. Mesylation, acidification, and basification of 19 produced (+)-N-Cbz-AP. Compound
(+)-N-Cbz-AP then underwent hydrogenolysis to form enantiopure (+)-AP·2HCl (Scheme
1.12).

Scheme 1.12. Tang et al synthesis of (+)-AP.
1.6.4. Eklund et al. approach
In 2012, Eklund et al. synthesized (–)-AP during the synthesis of (–)-absouline.22
They started their synthesis with the reduction of 20 to give the corresponding aldehyde,
which was subjected to Horner–Wadsworth–Emmons reaction to give 21a and 21b in 2:1
ratio. Compound 21a underwent conjugate addition of an amine to give an inseparable
mixture of 22a and 22b. The mixture of 22a and 22b was then converted into pyrrolizidines
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23a and 23b, which were easily separated by chromatography. The compound 23b was
then reduced with BH3·SMe2 and hydrogenolyzed to form (–)-AP·2HCl (Scheme 1.13).

Scheme 1.13. Eklund et al approach to make pyrrolizidine ring.
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Chapter 2. What happens if LolO expression is knocked down?
(This chapter has been published as part of “Ether bridge formation in loline alkaloid
biosynthesis” by Juan Pan, Minakshi Bhardwaj, Jerome R. Faulkner, Padmaja Nagabhyru,
Nikki D. Charlton, Richard M. Higashi, Anne-Frances Miller, Carolyn A. Young, Robert
B. Grossman, Christopher L. Schardl.23 This chapter’s experimental section reports only
the work done by me.)

Introduction:
In 2008, Dr. Jerome Faulkner observed the accumulation of an unknown metabolite
in the culture of E. uncinata after he used RNAi to knock down expression of the lolO
gene.16 Dr. Juan Pan later isolated the metabolite and tentatively identified it as AcAP
(Figure 2.1).23 Dr. Pan also observed that several Epichloë species (such as Epichloë.
amarillans strains E721, E722 and E862, Epichloë. brachyelytri E4804, and Epichloë.
canadensis e4814)23 with lolO mutations accumulated the same compound but did not
produce loline alkaloids. These observations suggested that the compound was an
intermediate in the biosynthetic pathway leading to loline alkaloids.

Figure 2.1. (±)-1-exo-Acetamidopyrrolizidine (AcAP) and its numbering scheme.
Dr. Juan Pan isolated enough of the new metabolite, which I used to determine its
formula and connectivity by MS and NMR, but NMR experiments to assign its
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stereochemistry gave ambiguous results. I decided to prepare AcAP synthetically in order
to compare its structure with that of the new metabolite and establish the structure of the
latter, including its stereochemistry, with certainty.

Results and discussion
2.2.1. Synthesis of ()-AcAP and ()-1-epi-AcAP
To make AcAP, I adapted (Scheme 2.1) the procedure for synthesis of AP
developed by Christine et al. (Scheme 1.10).19 Christine et al. used NaOMe as a base for
Dieckmann cyclization to cyclize diester 8, but I found that when I used LDA as a base,
our yield was higher than the reported yield.19 Hydrolysis, decarboxylation, and oxime
formation then gave (±)-10. I reduced (±)-10 with Raney Ni in THF to give AP along with
some 1-epi-AP, and allowed this mixture to react with Ac2O and DMAP to afford (±)AcAP in 8% yield over the two steps. The 1-epi-AP was not observed to react with Ac2O
under these conditions. By contrast, when I reduced (±)-10 with Pd/C/H2, I observed (±)1-epi-AcAP only.
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Scheme 2.1. Synthetic scheme to make (±)-AcAP and (±)-1-epi-AcAP.
2.2.2. HRMS and NMR analysis of synthetic ()-AcAP
The fact that only one of the diastereomers obtained from the Raney Ni reduction
reacted further with Ac2O made us confident that our AcAP had exo stereochemistry, but
I wanted to establish the stereochemistry of our presumed (±)-AcAP with absolute
certainty. Therefore, I analyzed its structure and stereochemistry with NMR and HRMS.
HRMS (Figure A.1) revealed that synthetic (±)-AcAP showed an [M + H] peak
with the molecular formula C9H17N2O. The HSQC spectrum (Figure 2.2) confirmed the
presence of 15 H atoms: two methine groups, five pairs of methylene groups, and one
methyl group.
The HSQC spectrum (Figure 2.2) showed that the two most downfield protons, at
4.12 and 3.26 ppm, were due to the methine H atoms at C(1) and C(8). Due to the greater
electronegativity of the amido functional group, I assigned the most downfield resonance
to the C(1) H atom. The HMBC spectrum (Figure A.2) supported this assignment, as there
was a correlation between the 1H NMR resonance at 4.12 ppm and the 13C NMR resonance
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due to C(10), a three-bond coupling (Figure 2.3). By contrast, there was no correlation in
the HMBC spectrum between the 1H NMR resonance at 3.26 ppm and the 13C NMR
resonance due to C(10).

Figure 2.2. 600 MHz 1H–13C HSQC NMR spectrum of ()-AcAP.

Figure 2.3. HMBC correlations between H atom at C(1) and acetyl group of AcAP.
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Figure 2.4. 600 MHz 1H–1H COSY NMR spectrum of (±)-AcAP.
I assigned the remainder of the resonances to H atoms on the basis of chemical
shifts and 1H-1H COSY correlations (Figure 2.4). The next most downfield resonance after
the C(1) proton was at 3.22 ppm, which could have been one of the C(3) protons, as it was
nearer to two N atoms as compared to others. I inferred from the HSQC spectrum that the
H atom resonating at 3.22 ppm was geminal to the H atom resonating at 2.61 ppm,
suggesting that these two resonances were due to the two H atoms at C(3). The resonance
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at 3.03 ppm could have been due to an H atom at C(5), as it was near to a N atom, and
HSQC showed that it was geminal to the H atom resonating at 2.61 ppm. COSY showed
the strongest correlation between the C(1) and C(8) H atoms and strong correlation between
the C(1) H atom and H atoms resonating at 1.73 ppm and 2.16 ppm, which HSQC showed
were a geminal pair (Figure 2.5). These data suggested that the H atoms resonating at 1.73
ppm and 2.16 ppm were at C(2). There was also a strong correlation in the COSY spectrum
between the C(2) resonances and those assigned to C(3), which supported the initial
assignment of the latter resonances.

Figure 2.5. COSY correlations between H atoms at C(1), C(2), C(3) and C(8) of AcAP.
In the COSY spectrum of AcAP, there was a strong correlation between the
resonance arising from the C(8) H atom and the resonances at 2.16 ppm and 1.60 ppm,
which HSQC showed were a geminal pair, suggesting that they could be assigned to the H
atoms at C(7) (Figure 2.6).

Figure 2.6. COSY correlations between H atoms at C(1), C(7) and C(8) of AcAP.
The remaining resonances at 1.73 ppm and 1.83 ppm, which HSQC showed were
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a geminal pair, showed strong correlations in the COSY spectrum with the resonances
arising from the C(7) and C(5) H atoms. These data suggested that these last two resonances
could be assigned to the H atoms at C(6) (Figure 2.7). The resonances at C(6) also showed
a strong correlation with the resonances that had previously been assigned to the C(5) H
atoms, further supporting our initial assignments.

Figure 2.7. COSY correlations between H atoms at C(6) and C(7) and between H atoms
at C(5) and C(6) of AcAP.
2.2.3. HRMS and NMR analysis of ()-1-epi-AcAP
Meanwhile, I was able to synthesize ()-1-epi-AcAP through the reduction of (±)10 with Pd/C/H2 (Scheme 2.1). The HRMS spectrum of ()-1-epi-AcAP (Figure A.3) was
similar to ()-AcAP, as expected for these diastereomers. The HSQC spectrum of ()-1epi-AcAP (Figure 2.8) showed the presence of the same numbers of methine groups (two),
methylene groups (five), and methyl groups (one) as its diastereomer.
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Figure 2.8. 400 MHz 1H–13C HSQC NMR spectrum of ()-1-epi-AcAP.
The two downfield resonances in the HSQC spectrum of compound ()-1-epiAcAP were methine H atoms, one at 4.41 ppm and the other at 3.84 ppm. I assigned the
4.41 ppm resonance to the H atom at C(1) due to its close proximity to an amido group.
The only remaining methine H atom in the structure was at C(8), allowing us to assign the
resonance at 3.84 ppm to it. I allotted the chemical shifts of the remaining protons with the
help of the COSY spectrum (Figure 2.9).
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Figure 2.9. 400 MHz 1H–1H COSY NMR spectrum of ()-1-epi-AcAP.
The resonances that I attributed to the H atoms at C(1) and N(9) showed a strong
correlation in the COSY spectrum (Figure 2.10), which further supported our assignment
of the C(1) H atom. The COSY spectrum showed no correlation between the resonances
that I attributed to the H atoms at C(8) and N(9).
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Figure 2.10. COSY correlation between H atoms at C(1) and N(9) of 1-epi-AcAP.

There was a strong correlation in the COSY spectrum between the resonance due
to the H atom at C(1) and resonances at 2.07 ppm and 1.69 ppm (Figure 2.11), which the
HSQC spectrum showed arose from a geminal pair. These data suggested that these
resonances were due to the two H atoms at C(2).

Figure 2.11. COSY correlations between H atoms at C(1) and C(2) of 1-epi-AcAP.
The resonance due to the H atom at C(8) showed a correlation in the COSY
spectrum with resonances at 1.69 ppm and 1.38 ppm (Figure 2.12), which the HSQC
spectrum showed arose from a geminal pair. These data suggested that these resonances
were due to the two H atoms at C(7).

Figure 2.12. COSY correlations between H atoms at C(7) and C(8) of 1-epi-AcAP.
After the resonances due to the H atoms at C(1) and C(8), the next most downfield
resonance in the 1H NMR spectrum of ()-1-epi-AcAP was at 3.22 ppm. This resonance
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could have arisen from an H atom at C(3) or one at C(5), as these H atoms were closest to
N as compared to the rest of the unassigned H atoms. In the HSQC spectrum, the resonance
at 2.85 ppm showed a geminal relationship with the resonance at 3.22 ppm. I assigned these
two resonances to the H atoms at C(3) due to their greater proximity to two electronegative
N atoms. This assignment then suggested that the remaining resonances at 3.22 ppm and
2.64 ppm, which the HSQC spectrum showed arose from geminal H atoms, should arise
from the H atoms at C(5).
The only unassigned H atoms left in ()-1-epi-AcAP were those at C(6). In the
COSY spectrum, the resonances that arose from the H atoms at C(5) and C(7) showed a
strong correlation with overlapping resonances at 1.79 ppm (Figure 2.13), which the HSQC
spectrum showed arose from a geminal pair. These data suggested that these resonances
arose from the H atoms at C(6).

Figure 2.13. COSY correlations between protons at, (A) C(6) and C(7); and (B) C(6) and
C(5) of 1-epi-AcAP.
2.2.4. NMR analysis of stereochemistry of ()-AcAP and ()-1-epi-AcAP
The COSY and HSQC NMR spectra helped us to assign the structures of both
diastereomers ()-AcAP and 1-epi-AcAP, but the relative stereochemistry of the H atoms
at C(1) and C(8) in the two diastereomers could not be determined until I considered
NOESY correlations (Figures 2.14 and 2.15).
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Figure 2.14. 400 MHz 1H–1H NOESY NMR spectrum of (±)-AcAP.
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Figure 2.15. 400 MHz 1H–1H NOESY NMR spectrum of ()-1-epi-AcAP.

To unambiguously establish the stereochemistry of C(1) relative to C(8) in (±)AcAP and ()-1-epi-AcAP, I looked for NOE interactions between the H atoms at N(9)
and C(1); N(9) and C(8); C(1) and C(7); and C(1) and C(8). In the NOESY spectrum of
(±)-AcAP, I observed correlations between one of the H atoms at C(7) and the H atom at
C(1), and between the H atoms at N(9) and C(8) (Figure 2.16). These correlations were

29

only possible in (±)-AcAP if the H atom at C(1) was trans with respect to the ring fusion
H atom at C(8). I did not observe these interactions in the NOESY spectrum of ()-1-epiAcAP, but I did observe correlations between the H atoms at C(1) and C(8), and between
the H atoms at C(1) and N(9) (Figure 2.17). These data strongly suggested that (±)-AcAP
was the exo isomer, and ()-1-epi-AcAP was the endo isomer.
However, I found a correlation in the NOESY spectrum of (±)-AcAP that was
difficult to explain with our assignment. The correlation was between the resonances due
to the H atom at C(1) and the resonance due to H atoms at C(8) and C(3). If the correlation
was to the H atom at C(8), it could be rationalized as being due to hopping (transfer of
energy from one atom to another) or COSY leakage. If the correlation was to the H atom
at C(3), it could be a transannular NOE. It was hard to distinguish between these
possibilities.

Figure 2.16. 1H–1H NOESY correlations between H atoms at C(1) and C(7), and C(8)
and N(9) in (±)-AcAP.
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Figure 2.17. 1H–1H NOESY correlations between H atoms at C(1) and C(8), and C(1)
and N(9) in (±)-1-epi-AcAP.
2.2.5. Crystal structure of synthetic ()-AcAP
I was able to grow crystals of (±)-AcAP from CHCl3 that were suitable for analysis
by X-ray crystallography, which allowed me to assign its stereochemistry unequivocally.
The crystals that I obtained were centrosymmetric, with each unit cell containing a single
complex consisting of a 2:1 ratio of (±)-AcAP to HCl (Figure 2.18). In this complex, the
ring N atoms of the two molecules of (±)-AcAP formed a linear N–H+–N arrangement, and
the two amide N-H groups coordinated to Cl–. There was a very short intramolecular N-HN bond (2.632 Å) in the crystal, which is rare but not unique for this type of compound.2426

In any case, the crystal structure clearly showed that the stereochemistry of the amido

group at C(1) of (±)-AcAP was exo with respect to the C(8) H atom, further supporting the
structure determined by NMR.
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Figure 2.18 ORTEP diagram of 2AcAP·HCl.
2.2.6. NMR and MS spectra of mixture of synthetic (±)-AcAP and isolated
metabolite were identical to those of individual samples

In order to determine whether synthetic (±)-AcAP was identical to putative isolated
AcAP, I mixed equimolar samples of the two materials in CDCl3, and I analyzed the
mixture by 1H NMR (Figure A.4) and 13C NMR (Figure A.5). There were no changes from
the NMR spectra of isolated and synthetic (±)-AcAP to the NMR spectra of the mixed
material. The GC–MS spectrum of the equimolar mixture was also indistinguishable from
the GC–MS spectra of the individual compounds (Figure A.6). These analyses established
that the new metabolite had a structure and stereochemistry identical to synthetic (±)AcAP, with the caveat, of course, that the isolated AcAP was almost certainly
enantiomerically pure.
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Conclusion
I have shown that AcAP is a novel metabolite that can be isolated from fungi that
have a mutated lolO gene. The natural conclusion is that AcAP is the substrate for LolO in
the loline biosynthetic pathway. However, there is also the possibility that AP, a known
intermediate, is the actual substrate of LolO, and that AcAP forms by reaction of AP with
an endogenous acetylase only when AP begins to accumulate because functional LolO is
absent. In other words, AcAP could be a shunt product, and may not be involved in the
biosynthesis of loline at all. In the following chapter, I will investigate whether AcAP is a
real intermediate or a shunt product.

Experimental Section
Ethyl (2S)-N-(3-ethoxy-3-oxopropyl)prolinate (8)

Ethyl L-prolinate (7) (10.0 g, 69.8 mmol) and ethyl acrylate (34.9 g, 349 mmol) were added
to the reaction vessel and were heated to reflux under nitrogen for 24 h. The reaction
mixture was allowed to come to RT, and excess ethyl acrylate was evaporated. It was
poured onto a silica column, then eluted with ethyl acetate:petroleum ether (4:6). The
solvent was evaporated to yield 16.9 g (98%, 69.5 mmol) of 8. 1H NMR (400 MHz,
CDCl3):  4.14 (q, 7.2 Hz, 2H), 4.09 (q, 7.2 Hz, 2H), 3.12 (ddt, Jd = 19.8 Hz, Jd = 8.1 Hz,
Jt = 4.2 Hz, 2H), 2.99 (dt, Jd = 12.2 Hz, Jt = 7.7 Hz, 1H), 2.70 (dt, Jd =12.2 Hz, Jt = 7.5
Hz, 1H), 2.48 (t, 7.6 Hz, 2H), 2.37 (q, 8.0 Hz, 1H), 2.12-1.97 (m, 1H), 1.96-1.68 (m, 3H),
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1.23 (t, 7.1 Hz, 3H), 1.20 (t, 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3):  14.3, 14.4, 23.3,
29.5, 34.0, 50.0, 53.4, 60.5, 60.7, 65.9, 172.4, 174.2. IR (ATR): 1729 cm-1.

(±)-1-Oximinopyrrolizidine ((±)-10)

A solution of n-BuLi (18.1 mL, 2.27 M) in hexane was added to a solution of
diisopropylamine (6.81 mL) in dry THF (225 mL) at –78 C. The reaction mixture was
stirred for 1 h. A solution of 8 (5.00 g, 20.6 mmol) in THF was prepared and added to the
above reaction mixture. The reaction mixture was stirred at –78 C for 2 h and then brought
to RT. Water (30.0 mL) was added to it, and the mixture was concentrated by evaporation
of THF. The reaction mixture was cooled to 0 C. Conc. HCl (30 mL) was added to it dropby-drop, and the mixture was heated to reflux for 1.5 h. The reaction mixture was adjusted
to pH 9 by adding a saturated solution of K2CO3 at 0 C. NH4OH·HCl (1.43 g, 20.6 mmol)
was added, and the mixture was heated to reflux for 2 h. The mixture was then left to stir
for 24 h. The crude compound was extracted with continuous extraction for 3 days with
CH2Cl2. The solvent was concentrated and poured onto a silica column, and then eluted
with CH2Cl2:CH3OH:NH4OH (8:2:0.2). Solvent was evaporated to yield 1.07 g (37%, 7.6
mmol) of (±)-10 as a light brown powder that consisted of an inseparable mixture of
diastereomers. 1H NMR (400 MHz, CD3OD):  4.09 (t, 7.7 Hz, 1H, minor), 3.82 (dd, 8.2
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Hz, 3.6 Hz, 1H, major), 3.19-2.85 (m, 6H, minor), 2.84-2.47 (m, 6H, major), 2.37-2.23 (m,
1H, major), 2.21-2.05 (m, 1H, minor), 2.00-1.70 (m, 3H). 13C NMR (100 MHz, CD3OD):
 (major) 25.9, 30.3, 30.9, 51.0, 54.13, 62.8, 161.2;  (minor) 25.9, 30.2, 30.9, 51.6, 54.1,
66.5, 165.9. IR (ATR): 3201, 1738, 1676 cm-1.
(±)-1-exo-Acetamidopyrrolizidine ((±)-AcAP)

Compound (±)-10 (0.29 g, 2.09 mmol) was dissolved in THF, and Raney Ni (in excess)
was added to it. The mixture was stirred for 13 h at RT as indicated by TLC for completion
of reduction to amine. Acetic anhydride (0.196 mL, 2.08 mmol) and DMAP (0.254 g, 2.08
mmol) were added to the reaction mixture, which was stirred at RT for 2 h. It was filtered
through a short bed of Celite, followed by dilution with CHCl3. The pH of the solution was
adjusted to 12 by adding 1 M NaOH, followed by an addition of saturated NaHCO 3 and
brine. The phases were allowed to separate for 30 min, and the aqueous layer was extracted
with CHCl3 twice. The organic layers were combined and dried over MgSO 4, filtered, and
concentrated. The residue was poured onto a silica column, then eluted with
CH2Cl2:CH3OH:NH4OH (6:4:1.5). Solvent was evaporated to yield 29 mg (8%, 0.17
mmol) of (±)-AcAP as white crystalline solid, mp 72-74 C. 1H NMR (400 MHz, CDCl3):
 1.63 (dq, Jd = 6.8 Hz, Jq = 13.2 Hz, 1H), 1.68-1.78 (m, 2H), 1.79-1.85 (m, 1H), 1.93 (s,
3H), 1.99 (dq, Jd = 7.0 Hz, Jq = 13.0 Hz, 1H), 2.16 (dq, Jd = 6.4 Hz, Jq = 12.6 Hz, 1H),
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2.62 (dq, Jd = 10.7 Hz, Jq = 7.0 Hz, 2H), 3.07 (dt, Jd = 10.7 Hz, Jt = 6.4 Hz, 1H), 3.29 (dt,
Jd = 11.3 Hz, Jt = 6.4 Hz, 1H), 3.35 (dt, Jd = 12.6 Hz, Jt = 6.4 Hz, 1H) 4.2 (app. quint., 6.4
Hz, 1H), 6.64 (broad d, 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3):  23.6, 25.6, 30.8,
33.0, 53.5, 55.4, 55.5, 71.0, 170.1. IR (ATR): 3272, 1649, 1554 cm-1. HRMS: m/z calcd
for C9H17ON2 (M + H): 169.1341; found: 169.1336.

(±)-1-endo-Acetamidopyrrolizidine ((±)-1-epi-AcAP)

Compound 10 (0.10 g, 0.73 mmol) was dissolved in THF and palladium charcoal (0.22 g)
was added to it and hydrogenated with a H2 balloon. The reaction mixture was stirred
overnight at RT as indicated by TLC for completion of reduction to amine. Acetic
anhydride (0.06 mL, 0.73 mmol) was added and stirred at RT for 2 h. The reaction mixture
was filtered through a short bed of Celite, followed by dilution with CHCl3. The pH of the
solution was adjusted to 12 by adding 1 M NaOH, followed by addition of saturated
NaHCO3 and brine. The phases were allowed to separate for 30 min and aqueous layer was
extracted with CHCl3 twice. The organic layers were combined and dried over MgSO 4. It
was filtered and concentrated. The residue was poured onto a silica column and eluted with
CH2Cl2:CH3OH:NH4OH (6:4:1.5). Solvent was evaporated to yield 12.7 mg (10%, 0.08
mmol) of (±)-1-epi-AcAP as yellow solid. 1H NMR (400 MHz, CDCl3):  5.51 (s, 1H),
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4.36 (dddd, 7.6 Hz, 6.6 Hz, 6.4 Hz, 6.3 Hz, 1H), 3.62 (q, 7.3 Hz, 1H), 3.05 (dt, Jd = 10.9
Hz, Jt = 6.4 Hz, 2H), 2.55 (dt, Jd = 10.8 Hz, Jt =6.9 Hz, 1H), 2.45 (ddd, 10.0 Hz, 8.2 Hz,
6.6 Hz, 1H), 2.07 (dq, Jd = 13.4 Hz, Jq = 6.8 Hz, 1H), 1.94 (s, 3H), 1.85-1.60 (m, 4H), 1.39
(dq, Jd = 12.5 Hz, Jq = 8.3 Hz, 1H); 13C NMR (100 MHz, CDCl3):  23.6, 25.6, 30.5, 32.6,
53.5, 54.8, 55.4, 71.6, 170.2; IR (ATR): 3258, 1667, 1547 cm-1. HRMS: m/z calcd for
C9H17ON2 (M + H): 169.1341; found: 169.1333
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Chapter 3. Is AcAP a shunt product or a substrate for LolO?

(This chapter has been published as part of “Enzymes from Fungal and Plant Origin
Required for Chemical Diversification of Insecticidal Loline Alkaloids in Grass-Epichloë
Symbiota” by Juan Pan, Minakshi Bhardwaj, Padmaja Nagabhyru, Robert B. Grossman,
Christopher L. Schardl.27 This chapter’s experimental section reports only the work done
by me.)

Introduction
The lolO gene belongs to the genome of loline-producing fungi.23 A homology
search of the genome sequence of various enzymes shows that LolO is a mononuclear nonheme iron oxygenase enzyme.27 LolO belongs to the superfamily of alpha-ketoglutarate
dependent enzymes.27 Enzymes of this family are known to catalyze a wide variety of
reactions, such as halogenation, hydroxylation, H-atom abstraction via C–H bond
activation, oxidative ring closure, desaturation, oxidative aromatic ring cleavage, and C=C
double bond epoxidation.28-29 Such enzymes play an important role in the biosynthesis of
antibacterial agents, neurotransmitters, and other metabolites.30
I discussed the new metabolite, AcAP in chapter 2, where I was able to establish
the structure and stereochemistry of AcAP by comparing it with synthetic (±)-AcAP. In
the present chapter, I will explore whether AcAP is a shunt product or a natural substrate
of LolO.23
There were two possible explanations (Scheme 3.1) for the accumulation of AcAP
when lolO was either mutated or subjected to RNAi. Our favored explanation was that
AcAP was an intermediate in the loline biosynthesis pathway, and that lolO catalyzed
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oxidative ether bridge formation on AcAP to make NANL (Scheme 3.1, Pathway A). The
hypothesis that AcAP was the intermediate could be explained by the reason that the
oxidative C–H bond activations catalyzed by LolO might go more smoothly in the presence
of the amide group of AcAP as compared to the more easily oxidized primary amino group
of AP. The other explanation was that AP was the intermediate and lolO catalyzed the
oxidative ether bridge formation on AP, resulting in the formation of NL as the first
tricyclic loline in the biosynthetic pathway. NL would then undergo acetylation to make
NANL (Scheme 3.1, Pathway B). If the latter hypothesis were true, then AcAP would be
only a shunt product, the result of an endogenous enzyme acting on AP accumulating in
the absence of LolO.23

Scheme 3.1. Alternative pathways that might explain accumulation of AcAP. Pathway A:
AcAP is an intermediate in loline biosynthesis. Pathway B: AcAP is a shunt product.

In order to determine which hypothesis was correct, we decided to feed (±)-AcAP
that had a D atom in both the ring and the acetyl group to loline-producing culture. This
experiment would allow us to determine which pathway the loline biosynthesis took. If
AcAP were the intermediate (Scheme 3.1, Pathway A), then the product NANL would
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retained all of the D. However, if AcAP were a shunt product (Scheme 3.1, Pathway B),
then any AcAP that converted to NANL would first have to be hydrolyzed to AP by
removal of the deuterated acetyl group, and hence the NANL would retain only D from the
ring.23

Results and discussion
3.2.1. Synthesis of 2´,2´,2´,3-[2H4]-AcAP
To distinguish which of the two pathways (Scheme 3.1, A and B) was operative, I
decided to synthesis (±)-AcAP that was labeled both in the pyrrolizidine ring and on the
acetyl group, which could be feed to loline-producing fungus in culture. My predecessor,
Dr. Hussaini, had previously prepared (±)-3,3-[2H2]-AP by replacing ethyl acrylate with
ethyl 3,3-[2H2]-acrylate in the Christine et al. procedure (Scheme 1.10).13 Adapting this
protocol, I prepared (+)-3,3-[2H2]-10, reduced it with Raney Ni in THF, and allowed the
product to react with acetic anhydride-d6 (Scheme 3.2). Sadly, the MS analysis of the
resulting AcAP showed that it consisted of about 85% tetradeuterated AcAP, 13%
trideuterated AcAP, and only trace amounts of desired pentadeuterated AcAP. The 1H
NMR spectrum of the material showed the presence of H atoms at the C(3) position, rather
than being fully deuterated as hoped. These results implied that Raney Ni must have
catalyzed the substitution of D with H. It may have been that Dr. Hussaini did not see as
much scrambling of D with H in our past syntheses of AP because he ran the reduction in
isopropanol, whereas I used THF. It is also possible that the Raney Ni that he used in his
reactions was less active than what I used.
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Scheme 3.2. Synthesis of 2´,2´,2´,3-[2H4]-AcAP.

Even though I lost one of the two D atoms from the pyrrolizidine ring, the fact that
one D atom was still present there in 85% of the material allowed us to move forward with
the feeding experiment with loline-producing culture.

3.2.2. Production of [2H4]-NANL upon feeding ()-2´,2´,2´,3-[2H4]-AcAP to lolineproducing culture

Dr. Juan Pan fed synthetic ()-2´,2´,2´,3-[2H4]-AcAP to loline-producing culture
of E. uncinata, e167. The GC-MS of the NANL that was produced showed peaks at m/z =
183 and m/z = 187 (Figure 3.1C). We knew that the 183 peak was due to NANL that was
produced from naturally produced AcAP (Figure 3.2b), so it seemed likely that the 187
peak was due to [2H4]-NANL that was produced from the added [2H4]-AcAP. We
concluded that AcAP was indeed an intermediate in loline alkaloid biosynthesis, acting as
the substrate for LolO.27
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Figure 3.1. (A) GC-MS total ion chromatogram of feeding of 2´,2´,2´,3-[2H4]-AcAP to
loline-producing culture; (B) mass spectrum showing undeuterated NANL at retention time
of 13.948 min; (C) mass spectrum showing incorporation of deuterium in NANL at
retention time of 13.921 min.27 (Figure by Dr. Juan Pan.)
Conclusion
We have established that acetylation occurs before ether bridge formation (Scheme
3.1, Pathway A), that AcAP is the substrate of LolO, and that NANL is the first loline
alkaloid in the biosynthetic pathway. It follows that all the loline alkaloids thereafter are
derived from NANL through various modifications of substituents on the exocyclic N atom
in NANL. However, these data do not tell us what is the product of LolO acting on AcAP.
I will investigate this interesting question in more detail in Chapter 4.
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Experimental Section
Ethyl (2S)-N-(3-ethoxy-3-oxo-1,1-dideuteropropyl)prolinate (1´,1´-[2H2]-8)

A solution of ethyl triphenylphosphonoacetate (25.0 g, 71.8 mmol) in dry acetonitrile (126
mL) was warmed to 50 C under nitrogen. Paraformaldehyde-d2 (2.29 g, 71.8 mmol) was
added to it, and the mixture was stirred for 16 h at 50 C. The reaction mixture was allowed
to come to RT, PPh3 (2.26 g, 8.61 mmol, 12 mol %) and 7 (10.3 g, 71.8 mmol) were added,
and the mixture was heated to reflux under nitrogen for 24 h. The reaction mixture was
allowed to come to RT and stirred for 48 h. The reaction mixture was concentrated and
poured onto a silica column and eluted with ethyl acetate:petroleum ether (4:6). The
solvents were evaporated to yield 14.3 g (81%, 58.3 mmol) of 1´,1´-[2H2]-8 as a yellow oil
. 1H NMR (400 MHz, CDCl3):  4.22-4.00 (m, 4H), 3.23-3.03 (m, 2H), 2.45 (s, 2H), 2.38
(q, 8.0 Hz, 1H), 2.19-2.03 (m, 1H), 1.97-1.69 (m, 3H), 1.33-1.16 (m, 6H). 2H NMR (61.5
MHz, CDCl3):  2.96 (broad s, 1H), 2.68 (broad s, 1H). 13C NMR (100 MHz, CDCl3): 
14.3, 14.4, 21.3, 23.3, 49.2 (quintet, 21.1 Hz), 53.3, 60.5, 60.8, 65.9, 172.4, 174.1.

(±)-3,3-Dideutero-1-oximinopyrrolizidine ((±)-3,3-[2H2]-10)
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This procedure was same as for the synthesis of (±)-10. We obtained (±)-3,3-[2H2]-10 (900
mg g, 6.36 mmol, 31%) as a mixture of inseparable diastereomers and as a light brown
powder. 1H NMR (400 MHz, CD3OD):  4.08 (t, 7.6 Hz, 1H, minor), 3.81 (dd, 8.1 Hz, 3.5
Hz, 1H, major), 2.99 (dq, Jd = 7.9 Hz, Jq = 4.7 Hz, 1H), 2.84-2.40 (m, 3H), 2.38-2.06 (m,
1H), 1.99-1.65 (m, 4H). 2H NMR (61.5 MHz, CDCl3 with CD3OD as impurity):  3.04
(broad s, 1H), 2.75 (broad s, 1H). 13C NMR (100 MHz, CD3OD):  (major) 26.1, 26.3,
31.1, 54.2, 64.5, 166.2, NCD2 not observed.  (minor) 26.4, 29.1, 30.3, 54.5, 63.0, 166.3,
NCD2 not observed, IR (ATR): 3206, 2207-2106, 1673 cm-1.

(±)-1-exo-(2,2,2-Trideuteroacetamido)-3-deuteropyrrolizidine (()-2´,2´,2´,3-[2H4]AcAP)
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The procedure was same as for the synthesis of (±)-AcAP, but instead of acetic anhydride,
acetic anhydride-d6 was used, affording 31.1 mg (8%, 0.18 mmol) of mostly ()-2´,2´,2´,3[2H4]-AcAP as a yellow solid, with the major impurity being ()-2´,2´,2´-[2H3]-AcAP. 1H
NMR (400 MHz, CDCl3):  1.61 (dq, Jd = 12.9 Hz, Jq = 6.9 Hz, 1H), 1.71 (dq, Jd = 12.9
Hz, Jq = 6.9 Hz, 2H), 1.81 (m, 1H), 1.95 (dq, Jd = 12.9 Hz, Jq = 6.9 Hz, 1H), 2.14 (~quintet,
5.9 Hz, 1H), 2.59 (broad s, 1H), 3.00 (broad s, 1H), 3.22 (broad d, 2H), 4.08 (~quintet, 6.9
Hz, 1H), 6.52 (broad d, 5.2 Hz, 1H). 2H NMR (61.5 MHz, CDCl3):  1.89 (broad s, 6H),
2.60 (broad s, 1H); 13C NMR (100 MHz, CDCl3):  22.8 (m), 25.5, 30.8, 32.8, 53.2 (m),
55.3, 55.4, 70.8, 170.3. IR (ATR): 3438, 2254, 1652 cm-1. HRMS: m/z calcd for
C9H13D4N2O (M+H): 173.1594; found: 173.1586.
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Chapter 4. What is the product of LolO acting on AcAP?
(Experiments for this chapter is reported in chapter 2)
Introduction
We have established that AcAP is the substrate acted upon by LolO, but we do not
know whether LolO oxidizes AcAP alone or with the help of other oxidizing enzymes
produced by the fungus. Four oxygenase enzymes (LolF, LolP, LolO and LolE) are
encoded in the LOL gene cluster. Previous studies have established that LolP catalyzes
oxidation of NML to NFL (Scheme 1.5) and is not involved in the biosynthetic pathway of
loline until after the formation of the first tricyclic loline. 23 LolF, identified as an FAD
monooxygenase, has been proposed to catalyze the oxidative decarboxylation of
pyrrolidine ring to iminium ion 5 (discussed in Chapter 1, Scheme 1.5)27 because the FAD
cofactor does not have enough oxidative potential to catalyze one of the C–H oxidations
necessary for ether bridge formation in AcAP. Therefore, LolE and LolO are the only
strong candidates for the installation of the ether bridge into AcAP.23 Moreover, it is
possible that LolO is catalyzing the hydroxylation of AcAP and that LolE is catalyzing the
subsequent ether bridge formation to make NANL, but it is also possible that LolO is
catalyzing both the oxidizing steps to make NANL, and LolE is not involved at all in the
process.23
To clarify the roles of LolO and LolE in ether bridge formation, we can feed (±)AcAP to a medium that contains LolO but not LolE. Two experiments that would
accomplish this goal are: (1) feeding synthetic AcAP to yeast into which lolO has been
cloned; and (2) feeding synthetic AcAP to purified LolO in vitro.
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Formation of ether bridge by single Fe/2-OG oxygenase (2-OG is 2-oxoglutarate)
through activations of two C–H bonds are rare but precedented. Only three enzymes,
clavaminic acid synthase (CAS), hyoscyamine 6β-hydroxylase (H6H), and AurH, a
cytochrome P450 monooxygenase are known to perform two C–H bond activations and
form a new oxacycle.
CAS, a 2-OG-dependent enzyme, catalyzes the key bond-forming step in the
clavulanic acid biosynthesis (Scheme 4.1). Clavulanic acid is a -lactam drug and is widely
used to inhibit serine -lactamases.31 CAS performs hydroxylation, oxidative bicyclization,
and desaturation.31-32 It is highly unusual for a single enzyme to do three transformations,
with two of those being C–H bond oxidations.

Scheme 4.1. C–H bond activation in clavunic acid biosynthesis.
H6H, another 2-OG-dependent enzyme, catalyzes the epoxidation of hyoscyamine
in scopolamine biosynthesis through two C–H bond activations (Scheme 4.2).
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Scopolamine is widely used for the treatment of motion sickness, Parkinson’s disease, and
eye inflammation.32-33

Scheme 4.2. C–H bond activations in scopolamine biosynthesis.
AurH, a cytochrome P450 monooxygenase, links two allylic C atoms with an O
atom to form an unstrained tetrahydrofuran in aureothin biosynthesis (Scheme 4.3).34-36

Scheme 4.3. C–H bond activation in aureothin biosynthesis.
Results and discussion
4.2.1. Production of NANL upon feeding synthetic ()-AcAP to yeast with lolO
expression
Scientists have long used yeast (Saccharomyces cerevisiae) as a host in studies that
require in vivo conditions to test the function of an enzyme. Dr. Juan Pan cloned lolO into
yeast and added ()-AcAP (I synthesized in chapter 2) to the modified organism. Upon
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GC-MS analysis of an extract, she observed a new peak (compare Figure 4.1b to Figure
4.1c) whose MS showed m/z = 183 (Figure 4.1a), consistent with NANL. The natural
conclusion was that LolO alone was sufficient to catalyze both C–H oxidations of AcAP
and formation of both C–O bonds of the ether bridge, a nearly unprecedented
transformation. However, it remained possible, though unlikely, that LolO catalyzed only
one hydroxylation, and that some other, endogenous enzyme in the yeast was catalyzing
the remaining C–O bond formation to give NANL.37

Figure 4.1. (a) Mass spectrum of NANL; (b) GC-MS total ion chromatogram of extract
from feeding of ()-AcAP to yeast expressing LolO; (c) GC-MS total ion chromatogram
of extract from feeding of ()-AcAP to yeast with vector-only (plasmid without lolO)
transformation.37 (Figure created by Dr. Juan Pan.)
4.2.2. Purified LolO enzyme catalyzes conversion of (±)-AcAP to NANL
To further support our hypothesis that AcAP was a substrate of LolO and that LolO
alone catalyzed formation of the ether bridge, Dr. Chang, who was a post-doctoral scholar
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in Dr. Bollinger lab at Penn State University constructed a plasmid to overexpress an Nterminally His6-affinity-tagged LolO in E. coli. He then purified the LolO produced by the
transformed E. coli with nickel column chromatography. He incubated the purified LolO
with 4 equivalents of synthetic ()-AcAP (I synthesized in chapter 2) in the presence of the
two cosubstrates, 2-OG and O2, and he analyzed the reaction mixture by LC-MS. He
observed the consumption of AcAP and production of NANL. This result proved that LolO
was the only enzyme needed to convert AcAP to NANL (Scheme 4.4).

Scheme 4.4 LolO catalyzes the oxidation of AcAP and 2-OG to NANL.

Dr. Chang also observed the production of a compound of mass 16 amu more than
AcAP (Figure 4.2). When the ratio of 2-OG to the natural enantiomer of AcAP was 0.5
(same as 2-OG:enzyme = 1), he observed the maximum amount of this compound. As he
increased the ratio of 2-OG to the natural enantiomer of AcAP to 2 (2-OG:enzyme = 4),
the amount of the novel compound decreased, and the amount of NANL increased, until
the ratio of AcAP to the novel compound to product NANL was approximately 1:0:1, as
one would expect if all of the natural enantiomer of AcAP, and none of the unnatural
enantiomer, had been converted to NANL. On the basis of its MS and its concentration’s
gradual increase, and then decrease, with increasing amounts of 2-OG, we tentatively
identified the compound as the presumed intermediate in oxacycle formation, 2- or 750

hydroxy-AcAP (Scheme 4.4). To our surprise, when Dr. Chang further increased the ratio
of 2-OG to the natural enantiomer of AcAP to 4, it appeared that the amount of AcAP
continued to decrease, and the amount of NANL appeared to continue to increase. Enzymes
usually prefer the natural enantiomer of their substrate and do not react with the unnatural
one. However, LolO seemed to be consuming its unnatural substrate in the presence of an
excess of 2-OG. We hypothesized that LolO might be converting the unnatural enantiomer
of AcAP not to NANL, but to a species with the same m/z as NANL, perhaps a ketone.
However, if unnatural enantiomer of AcAP was converting to NANL then LolO is
promiscuous.

B

Figure 4.2 LCMS of LolO incubation with various concentrations of ()-AcAP (4:1 with
respect to enzyme) and cosubstrates 2-OG and O2.
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Conclusion
We have shown that LolO alone catalyzes ether bridge formation in AcAP and that NANL
is the product of the reaction of LolO with AcAP. We have observed a new compound of
mass 16 amu more than AcAP and that appears to be an intermediate in the oxidation
reaction, and we have tentatively identified it as either 2- or 7-hydroxy-AcAP (Scheme
4.4); the evidence obtained thus far does not allow us to determine which is more likely.
In the next chapter, we will investigate the regiochemistry of this previously unknown
intermediate in more detail.
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Chapter 5. What is the sequence of C-O bond formation events catalyzed by LolO?

Introduction
In the experiment where we subjected (±)-AcAP to purified LolO and varying
concentrations of 2-OG (Scheme 4.4), we observed a novel compound that reached its
maximum concentration at low concentrations of 2-OG and nearly disappeared when the
concentration of 2-OG reached twice that of the natural enantiomer of AcAP (Figure 4.2)
The MS data showed that the unidentified compound had a mass 16 amu more than (±)AcAP and 2 amu more than NANL. These observations suggested that this compound was
an alcohol intermediate along the pathway from AcAP to NANL. What remained unclear,
however, was whether this alcohol was installed at the C(2) or C(7) position of AcAP
(Scheme 4.4).
The active site of LolO catalysis is not known yet. However, the active sites of 2OG-dependent enzymes such as LolO are generally conserved.38 The LolO active site
consists of a 2-His-1-carboxylate facial triad,29 which is formed by two histidine residues
and either aspartic acid coordinated to the octahedral mononuclear ferrous ion center
(Figure 5.1). The other remaining sites around the iron center are available for binding with
O2, 2-OG and substrate during enzyme catalysis but are typically occupied by water
molecules.39 The substrate coordinates the enzyme near the active site while O 2 and 2-OG
coordinate directly to the metal center (Scheme 5.1).40-41 Generally, 2-OG-dependent
enzymes couple the oxidation of their primary substrate with a four-electron reduction of
O2. Two electrons are provided by the oxidation of the primary substrate, and the remaining
two electrons are provided by the oxidation of 2-OG (cosubstrate) in order to completely
reduce O2.42
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Figure 5.1. Active site of 2-OG dependent enzyme.
As shown in Scheme 5.1, the commonly accepted mechanism for 2-oxoglutaratedependent enzymes starts with binary complex A.39 Coordination of 2-OG with
displacement of two molecules of H2O gives ternary complex (B). Complex B absorbs at
530 nm due to a metal-to-ligand charge transfer transition. Coordination of substrate with
the displacement of another molecule of H2O results in the formation of quaternary
complex C. One of the O atoms in O2 coordinates directly to the iron(II) center, while the
uncoordinated O atom attacks the 2-OG carbonyl C atom to give an Fe(IV)=O intermediate
complex F with the formation of CO2 and succinate. Complex F absorbs at 318 nm due to
the loss of the metal-to-ligand charge transfer. The highly reactive F begins the oxidation
of the substrate by abstraction of an H atom from an unactivated C atom of the substrate,
resulting in the formation of substrate radical and Fe(III)-OH intermediate complex G. The
hydroxylation of the substrate results from a rebounding of OH from G to the substrate
radical. The hydroxylated product dissociates, resulting in initial binary complex A, which
restarts the catalytic cycle.
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Scheme 5.1. General mechanism for 2-OG-dependent enzymes.
The substitution of an H atom with a D atom on the target C atom of the substrate
causes the rate of decay of the Fe(IV)=O intermediate complex (Scheme 5.1, complex F)
to decrease due to a kinetic isotope effect. It follows that if replacement of H with D in a
substrate causes F to accumulate, then the C atom bearing D must be involved in the C–H
bond-cleaving step.43 To determine which carbon atom of AcAP is hydroxylated first, we
could introduce D into the C(2) or C(7) position of AcAP. We could then subject these
isotopomers to the LolO oxidation reaction in conditions under which only the first C–H
activation event was expected to occur. If oxidation at C(2) occurred first, we would expect
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to see accumulation of F in the case of the C(2) isotopomer, but not the C(7) isotopomer.
By contrast, if oxidation at C(7) occurred first, we would expect to see the opposite.
The oxidation reaction that LolO catalyzes proceeds on the time scale of a few
milliseconds. A technique that can measure the kinetics of reactions that take place on the
time scale of a few milliseconds would help us to determine at which site in AcAP the
hydroxylation reaction occurs. One of these techniques is stop-flow absorption, which
monitors the reaction by measuring changes in the UV/Vis region of the electromagnetic
spectrum.30 As shown in Figure 5.2, in the experimental apparatus used for stop-flow
absorption, we usually have a reagent and a sample in two different syringes, which a
syringe drive pushes into the mixing chamber. The syringe drive keeps pushing the reagent
and the sample continuously through the observation cell into the stopping syringe until
the

stopping

block

is

reached.

Thereafter,

reaction

kinetics

are

measured

spectrophotometrically by measuring UV/Vis spectra, circular dichroism, refractive index,
NMR spectra, etc. The time between the end of mixing and the start of measurement is
dead time, which is usually a few milliseconds for stop-flow absorption.44 We can use stopflow absorption to resolve the two steps of oxidation of AcAP without altering the rate and
other kinetic measurements.
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Figure 5.2. Schematic diagram of a stopped-flow analyzer.
Results and discussion
In order to carry out the stop-flow absorption experiments, I needed to prepare
AcAP isotopomers that were deuterated separately at C(2) and C(7). Because I did not
know whether LolO was abstracting the exo or endo H atoms of C(2) and C(7), I decided
to make substrates that were fully deuterated at these positions. This decision also made
my synthetic work much simpler, because I did not need to prepare diastereomerically pure
compounds.

5.2.1. Synthesis of (±)-7,7-[2H2]-AcAP
To place two D atoms at the C(7) position of (±)-AcAP, I synthesized 24 (Scheme
5.2) by literature procedure45, then reduced 24 with NaBD4 to give 2513. Compound 25 was
then tosylated, reduced again with NaBD 4, and deprotected with 6 M HCl to make the
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racemic dideuterated proline, ()-3,3-[2H2]-Pro·HCl. This compound was further
esterified and subjected to a conjugate addition to make diester ()-3,3-[2H2]-8. The diester
()-3,3-[2H2]-8

was

then

subjected

to

Dieckmann

condensation,

hydrolysis,

decarboxylation, and NH4OH·HCl addition to give oxime ()-7,7-[2H2]-10.
Previously, I had used Raney nickel to reduce 3,3-[2H2]-10 to ()-2´,2´,2´,3-[2H4]AcAP (Scheme 3.2).27 Apart from giving low yields, Raney Ni also caused a large amount
of H/D exchange, resulting in retention of only one D atom in the ring. The scrambling of
D with H was even more thorough during the reduction of ()-7,7-[2H2]-10. Consequently,
I had a great need to find a reducing agent which could give an acceptable yield of AcAP
without any observable H/D exchange. After an extensive literature search and much
experimentation with various widely used reducing agents, I found that when Back et al.
used nickel boride (generated in situ) for the reductive cleavage of deuterated selenides,
they did not observe any H/D exchange.46 Therefore, I subjected ()-7,7-[2H2]-10 to nickel
boride (generated in situ) followed by Ac2O. To our delight, I obtained ()-7,7-[2H2]AcAP (97% d2 by HRMS) with no observable loss of D enrichment during the reduction.
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Scheme 5.2. Synthesis of (±)-7,7-[2H2]-AcAP.
5.2.2. Synthesis of (±)-2,2,8-[2H3]-AcAP
To place D at the C(2) position, I synthesized diester 8 following the previously
described procedure (Scheme 2.1).13 I then subjected 8 to Dieckmann condensation, using
DCl in D2O instead of aqueous HCl for hydrolysis and decarboxylation, and added
NH2OH·HCl to give ()-2,2,8-[2H3]-10 (Scheme 5.3). Nickel boride reduction of ()2,2,8-[2H3]-10 again proceeded well without any loss in D enrichment, and subsequent
acetylation gave ()-2,2,8-[2H3]-AcAP (88% d3 by HRMS).
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Scheme 5.3 Synthesis of (±)-2,2,8-[2H3]-AcAP.
5.2.3. Results of incubation of LolO with deuterated derivatives of (±)-AcAP
Dr. Juan Pan incubated (±)-AcAP, (±)-7,7-[2H2]-AcAP, and 2,2,8-[2H3]-AcAP
with LolO separately under limiting amounts of O2 and 2-OG. She observed that the
quaternary LolO iron(II) complex absorbed at 520 nm in all three substrates. She also
observed that, upon the addition of air-saturated buffer, all three substrates caused a
temporary increase in absorption at 318 nm, but the increase was much larger and lasted
much longer when (±)-2,2,8-[2H3]-AcAP was the substrate (Figure 5.3). The much larger
and longer-lasting increase in absorption at 318 nm in the case of (±)-2,2,8-[2H3]-AcAP
showed that the LolO ferryl complex F (Scheme 5.1) was accumulating to a much greater
extent due to a decrease in its rate of decay (Kdecay = 1.83 x 10-3 s-1) resulting from a
deuterium kinetic isotope effect of kH/kD = 25.96. The data showed that hydroxylation was
much slower when the C(2) position was deuterated than was the case when the C(7)
position was deuterated. We concluded that LolO oxidized (±)-AcAP at the C(2) position
first, resulting in the formation of the intermediate 2-hydroxy-AcAP before the ether bridge
was completed.
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kformation (s-1)

kdecay (10-3 s-1)

kH/kD

63.8 ± 0.79

47.5 ± 0.47

69.7 ± 0.85

49.9 ± 0.48

69.1 ± 0.48

1.83 ± 0.01 25.96 ± 0.03

1.05 ± 0.04

Figure 5.3. Stop-flow absorption showing accumulation of C–D cleaving LolO ferryl
complex F with (±)-2,2,8-[2H3]-AcAP, and not in the cases of (±)-AcAP and (±)-7,7-[2H2]AcAP. (Figure by Dr. Juan Pan.)
Characterization of hydroxylated intermediate by NMR
Further support for the hypothesis that hydroxylation of AcAP occurred first at C(2)
was provided by Dr. Juan Pan. She oxidized AcAP with LolO under conditions of limited
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2-OG, and she used prep HPLC to separate the observed intermediate from unreacted
AcAP and product NANL, although the sample of intermediate that she obtained contained
large amounts of NH4OAc and one or two other unidentified compounds. Despite the large
amounts of impurities, I was able to confirm by 1H NMR that the structure of the
hydroxylated intermediate was 2-hydroxy-AcAP (Figure 5.4). The NMR spectrum
featured doublets of doublets at 3.15 ppm (J = 12.6 Hz and 6.6 Hz) and 3.80 ppm (J = 12.7
Hz and 5.7 Hz). In the 1H NMR spectrum of 2-hydroxy-AcAP, I would expect to see a
doublet of doublets for the H atoms at C(3), but I would not expect to see such a pattern in
the 1H NMR spectrum of 7-hydroxy-AcAP. This evidence provided independent support
for the conclusion from the stop-flow experiment that the observed intermediate was 2hydroxy-AcAP, the product of hydroxylation of AcAP at C(2).

Figure 5.4. 500 MHz 1H NMR spectrum of the intermediate, 2-hydroxy-AcAP.
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Other aspects of the NMR spectra of 2-hydroxy-AcAP were thoroughly consistent
with the assigned structure. In the 1H–1H COSY spectrum, the doublets of doublets at 3.15
ppm and 3.80 ppm showed strong correlation with one another and with the most downfield
resonance, a quartet at 4.41 ppm, which I attributed to the C(2) H atom due to its proximity
to the electronegative oxygen in the hydroxyl group. The only methylene C atom near to
C(2) is C(3), allowing us to assign the two doublets of doublets to the C(3) H atoms. The
other two resonances downfield of 4.0 ppm, those at 4.17 and 4.07 ppm, were likely due to
the C(1) and C(8) H atoms. The resonance assigned to C(2) showed strong correlation with
the resonance at 4.17 ppm and not with the resonance at 4.07 ppm, suggesting that the
former resonance was due to the H atom at C(1) and the latter was due to the H atom at
C(8). The strong correlation in the COSY spectrum between the resonances arising from
C(2) and C(1) further supported our assignments.
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Figure 5.5. 400 MHz 1H–1H COSY NMR spectrum of the intermediate, 2-hydroxy-AcAP.

Figure 5.6. COSY correlations between H atoms at C(1), C(2), C(3), and C(8) in 2hydroxy-AcAP.
There are seven downfield resonances (each integrating to 1H) between 3.5 ppm
and 4.5 ppm in the 1H NMR spectrum of 2-hydroxy-AcAP. Out of seven, I already assigned
five as C(1), C(2), C(3) and C(8). I assigned the remaining downfield resonances, at 3.65
ppm and 3.36 ppm, to the H atoms at C(5) due to their proximity to the electronegative ring
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N atom. The remaining resonances in the region of 1.9 to 2.4 ppm, which integrate to 4H,
are likely due to the H atoms at C(6) and C(7).
Furthermore, when I irradiated the resonance attributed to the H atom attached to
C2 (quartet at 4.42 ppm), there was strong NOE enhancements of two resonances—one
attributed to the H atom attached to C8 (quartet at 4.08 ppm) and one attributed to one of
the two H atoms attached to C3 (dd at 3.90 ppm)—but only a very small NOE enhancement
of the resonance attributed to the H atom attached to C1 (triplet at 4.18 ppm) (Figure 5.7).
These data were consistent with 2-endo-hydroxy-AcAP, but not 2-exo-hydroxy-AcAP, as
I expected because of the endo orientation of the C2–O bond in NANL.

Figure 5.7. 600 MHz NOE difference spectrum of 2-hydroxy-AcAP in D2O upon
irradiation of the resonance at H2 at 4.42 ppm.
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Conclusion
Our results show that LolO begins C–O bond formation in AcAP by C–H activation
at C(2), presumably to give a radical intermediate. Hydroxylation then occurs at this
position to give 2-endo-hydroxy-AcAP. LolO could then catalyze a second C–H activation
at C(7), and subsequent addition of the C(2) O atom to the presumed radical at C(7) forms
the ether bridge of NANL (Scheme 5.4).

Scheme 5.4. Oxidation occurs first at C(2) and then at C(7) in AcAP to produce NANL.
Experimental Section
(±)-2,2,8-Trideutero-1-oximinopyrrolizidine ((±)-2,2,8-[2H3]-10)

A solution of n-BuLi in hexane (2.50 M, 11.1 mL) was added to a solution of
diisopropylamine (4.60 mL) in dry THF (100 mL) at –78 C under nitrogen. After 45 min,
a solution of 8 (3.40 g, 13.8 mmol) in THF was added dropwise. The reaction mixture was
stirred at –78 C for 18 h and then brought to RT. D2O (30.0 mL) was added, and then 7.7
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M DCl in D2O (35.0 mL) was slowly added to the reaction mixture at 0 C. The mixture
was heated to reflux for 1.5 h. The pH of the reaction mixture was adjusted to 9 by dropwise
addition of saturated K2CO3 in D2O at 0 C. NH4OH·HCl (0.96 g, 13.8 mmol) was then
added, and the mixture was heated to reflux for 2 h. The mixture was then stirred for 24 h.
Solvent and water were evaporated, and the crude mixture was extracted with CH2Cl2. The
solvent was concentrated and poured onto a silica column and then eluted with
CH2Cl2:CH3OH:NH4OH (8:2:0.2). The solvent was evaporated to yield (±)-2,2,8-[2H3]10 (0.49 g, 3.47 mmol, 25%) as a light brown powder and as an inseparable mixture of
diastereomers. 1H NMR (400 MHz, CD3OD):  3.17-2.50 (m, 4H), 2.33-2.18 (m, 1H,
major), 2.17-2.05 (m, 1H, minor), 1.99-1.50 (m, 3H). 2H NMR (61.5 MHz, CDCl3):  4.07
(broad s, minor), 3.82 (broad s, major), 2.88-2.21 (merged broad singlets). 13C NMR (100
MHz, CD3OD):  (major) 26.5, 29.0 (m), 31.1, 51.7, 54.5, 66.2 (t, 21.8 Hz), 166.3; 
(minor) 26.2, 30.5, 51.1, 54.3, 64.2 (t, 21.8 Hz), 166.1. IR (ATR): 3195, 2177, 1844, 1675,
1509 cm-1. HRMS: m/z calcd for C7H10D3ON2 (M + H): 144.1211; found: 144.1210.

(±)-1-exo-2,2,8-Trideuteroacetamidopyrrolizidine ((±)-2,2,8-[2H3]-AcAP)

Sodium borohydride (0.24 g, 6.25 mmol) was added in portions to a solution of (±)-2,2,8[2H3]-10 (96 mg, 0.67 mmol) and NiCl2 (0.26 g, 2.01 mmol) in anhydrous MeOH:THF
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(3:1, 5.0 mL) at –60 °C over a period of 2 h under nitrogen. (Caution: gas evolution!) After
complete addition, the resulting black slurry was allowed to warm up to –30 °C and stirred
at this temperature until no more starting material was detected by TLC (18 h). The reaction
mixture was warmed to RT, and Ac2O (in excess) was added with vigorous stirring. The
heterogeneous mixture was stirred for a further 4 h. Concentrated ammonium hydroxide
(10.0 mL) was added with stirring, and the mixture was filtered through a short pad of
Celite. The organic solvent was evaporated, and the aqueous layer was extracted with DCM
(3 times). The combined organic layers were washed with brine (2 times), dried over
anhydrous MgSO4, and concentrated in vacuum. The crude product was purified by flash
chromatography in CH2Cl2:CH3OH:NH4OH (6:4:0.2) to afford (±)-2,2,8-[2H3]-AcAP (28
mg, 0.16 mmol, 25% yield) as a gummy yellow solid. 1H NMR (400 MHz, CDCl3):  1.60
(dt, Jt = 7.4 Hz, Jd = 12.3 Hz, 1H), 1.74 (dq, Jd = 12.4 Hz, Jt = 6.9 Hz, 1H), 1.83 (ddt, Jd
= 18.6 Hz, Jd = 7.4 Hz, Jt = 6.2 Hz, 1H), 1.97 (overlapping s, 4H), 2.61 (dt, Jd = 11.9 Hz,
Jt = 6.6 Hz, 2H), 3.00 (dt, Jd = 10.5 Hz, Jt = 6.3 Hz, 1H), 3.18 (d, Jd = 10.6 Hz, 1H), 4.10
(d, Jd = 8.0 Hz, 1H), 5.88 (broad s, 1H). 2H NMR (61.5 MHz, CDCl3):  3.20 (broad s,
1H), 2.18 (broad s, 1H), 1.68 (s, 1H). 13C NMR (100 MHz, CDCl3):  23.6, 25.6, 30.7,
53.3, 55.3, 55.5, 170.1. IR (ATR): 3257, 2239 (weak), 1652, 1552 cm-1. HRMS: m/z calcd
for C9H14D3ON2 (M + H): 172.2583; found: 172.1524.

1,2-Di-tert-butyl-3-hydroxy-3-deuteropyrrolidine-1,2-dicarboxylate (25)
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NaBD4 (1.83 g, 43.9 mmol) was added to a solution of 24 (5.01 g, 17.6 mmol) in dry THF
(66 mL) at 0 ºC in small portions over a period of 1 h. The reaction mixture was stirred for
3 h at 0 ºC and warmed to RT. The solvent was evaporated, and the residue was dissolved
in CH2Cl2. The pH of the reaction mixture was adjusted to 2 by the dropwise addition of
1 N HCl with stirring at 0 ºC. The organic layers were washed with brine, dried with
MgSO4, and evaporated to give 25 (4.61 g, 15.9 mmol, 91% yield) as a light yellow powder
and as a mixture of diastereomers. 1H NMR (400 MHz, CDCl3) δ 1.36 (s, 9H; major), 1.38
(s, 9H; minor), 1.40 (s, 9H; minor), 1.41 (s, 9H; major), 1.88–2.05 (m, 2H), 3.25–3.64 (m,
2 H), 4.12 (s, 1H; major), 4.17 (s, 1H; minor). 2H NMR (61.5 MHz, CDCl3):  4.44 (broad
s, 1H). 13C NMR (100 MHz, CDCl3) δ (major) =28.1, 28.3, 31.8, 43.8, 64.1, 71.8 (t, 22.3
Hz), 80.0, 81.4, 154.1, 169.6; δ (minor) = 28.0, 28.4, 32.4, 44.2, 63.8, 70.9 (t, 22.0 Hz),
79.7, 81.5, 154.3, 169.7. IR (ATR): 3428, 2165, 1736, 1678 cm-1. HRMS: m/z calcd for
C14H25DNO5 (M + H): 289.3621: found: 289.1868.

1,2-Di-tert-butyl 3,3-dideuteropyrrolidine-1,2-dicarboxylate (27)

To the mixture of 25 (13.9 g, 48.5 mmol) and DMAP (5.92 g, 48.5 mmol) in dry CH2Cl2
(320 mL), triethylamine (49.1 mL, 48.5 mmol) was added. The reaction mixture was
cooled to 0 ºC, and TsCl (10.7 g, 56.2 mmol) was added in portions over 1 h. Stirring was
continued for a further 54 h at 0 ºC. A saturated solution of NH 4Cl was added to the reaction
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mixture at 0 ºC, and the aqueous layer was extracted with CH2Cl2. The combined organic
extracts were washed with brine, dried with MgSO4, and evaporated. Silica gel
chromatography (30% EtOAc in petroleum ether) afforded tosylate 26 (9.83 g, 22.2 mmol,
46% yield). The crude 26 was taken to the next step without purification.
NaBD4 (5,76 g, 13.8 mmol) was added to a solution of crude 26 (10.5 g, 23.8 mmol)
in dry DMSO (310 mL), and the mixture was heated to 95 ºC under nitrogen for 8 h. The
reaction mixture was cooled and diluted with brine (effervescence) and extracted with
ether. The combined organic layers were dried over MgSO 4, and the solvent was
evaporated. Flash chromatography (40% EtOAc in petroleum ether) afforded 27 (4.83g,
17.7 mmol, 79% yield) as a white gum. 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H; major),
1.45 (s, 9H; minor), 1.47 (s, 9H; major), 1.48 (s, 9H; minor), 1.77–1.97 (m, 2H), 3.47 (m,
2H), 4.10 (s, 1 H; major), 4.18 (s, 1 H; minor). 2H NMR (61.5 MHz, CDCl3):  1.81 (broad
s, 1H), 2.07 (broad s, 1H). 13C NMR (100 MHz, CDCl3) δ (major) =23.3, 28.1, 28.4, 30.3
(p, 20.25 Hz), 46.4, 59.6, 79.6, 80.8. 154.0, 154.4, 172.4; δ (minor) = 24.1, 28.0, 28.5, 29.3
(p, 20.25 Hz), 46.6, 59.6, 79.4, 153.8, 153.8, 172.3. IR (ATR): 2283-2162, 1737, 1697 cm1.

GC-MS (EI): 217 (5%), 203 (2%), 187 (3%), 172 (25%), 144(17%), 116 (100%), 72

(97%), 57 (95%).
(±)-3,3-Dideuteroproline hydrochloride ((±)-3,3-[2H2]-Pro·HCl)
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Aqueous HCl (6.0 M, 50 mL) was added to a solution of 27 (9.21 g, 33.7 mmol), and the
reaction mixture was stirred for 2 h at RT. The water was evaporated to give 3,3-[2H2]Pro·HCl (2.82 g, 18.4 mmol, 55%) as a brown gum. 1H NMR (400 MHz, D2O) δ 2.04 (t,
7.3 Hz, 2H), 3.40 (qt, Jt = 7.3 Hz, Jq = 11.8 Hz, 2H), 4.42 (s, 1H). 2H NMR (61.5 MHz,
D2O):  2.14 (broad s, 1H), 2.41 (broad s, 1H), 8.39 (broad s, 1H), 8.92 (broad s, 1H).
13CNMR

(100 MHz, D2O) δ 25.7, 30.2 (p, 20.8 Hz), 48.7, 62.0, 174.3. IR (ATR): 3359,

2032-1926, 1727, 1626 cm-1. EI-MS: Positive ion 117.9 amu, negative ion 173 amu.
(±)-Ethyl 3,3-dideuteroprolinate ((±)-3,3-[2H2]-7)

The compound 3,3-[2H2]-Pro·HCl (3.15 g, 20.5 mmol) was suspended in ethanol (28 mL)
and heated to 60 ºC. Thionyl chloride (12.2 g, 102 mmol) was added dropwise to the above
suspension, and the resulting solution was refluxed for 4 h. Excess thionyl chloride and
ethanol were evaporated, and the resulting solid was dissolved in CH2Cl2 (18 mL). Water
(3 mL) was added to the reaction mixture, and concentrated ammonia (5 mL) was added
to it dropwise. The aqueous layer was extracted with CH 2Cl2. The combined organic layers
were dried over MgSO4, and the solvent was evaporated to afford (2.1 g, 14 mmol, 69%)
()-3,3-[2H2]-7 as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 1.28 (t, 7.1 Hz, 3H), 1.651.84 (m, 2 H), 2.92 (dt, Jd = 10.2 Hz, Jt = 6.7 Hz, 1H), 3.08 (dt, Jd = 10.2 Hz, Jt = 6.8 Hz,
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1H), 3.75 (s, 1H), 4.18 (q, 7.1 Hz, 2H). 2H NMR (61.5 MHz, CDCl3):  1.68 (broad s, 1H),
1.96 (broad s, 1H). 13C NMR (100 MHz, CDCl3) δ 14.1, 25.1, 29.5 (p, 20.3 Hz), 46.9,
59.5, 60.1, 175.1. IR (ATR): 3347, 2230-2125, 1727 cm-1. GC-MS (EI): 145 (5%), 72
(100%), 55 (2%).

(±)-Ethyl (2S)-N-(3-ethoxy-3-oxopropyl)-3,3-dideuteroprolinate ((±)-3,3-[2H2]-8)

The compound ()-3,3-[2H2]-7 (2.06 g, 14.7 mmol) and ethyl acrylate (7.09 g, 70.8 mmol)
were added to the reaction vessel and refluxed under nitrogen for 24 h. The reaction mixture
was allowed to come to RT and concentrated. It was poured onto a silica column, then
eluted with 40% EtOAc in petroleum ether. The solvent was evaporated to yield ()-3,3[2H2]-8 (2.97 g, 12 mmol, 85%) as a yellow oil. 1H NMR (400 MHz, CDCl3):  1.25 (t,
7.1 Hz, 3H), 1.28 (t, 7.1 Hz, 3H), 1.75-1.95 (m, 2H), 2.43 (q, 8.5 Hz, 1H), 2.52 (t, 7.6 Hz,
1H), 2.71-2.81 (m, 1H), 3.04 (dt, Jd = 12.2 Hz, Jt = 7.7 Hz, 1H), 4.15 (td, Jd= 3.4 Hz, Jt =
8.0 Hz, 1H), 3.21 (s, 1H), 4.13 (q, 7.1 Hz, 2H), 4.18 (q, 7.1 Hz, 2H). 2H NMR (61.5 MHz,
CDCl3):  1.71 (broad s, 1H), 1.88 (broad s, 1H). 13C NMR (100 MHz, CDCl3):  13.8,
13.9, 22.8, 28.5 (p, 20.1 Hz), 33.6, 49.5, 52.9, 60.0, 60.2, 65.3, 171.8, 173.6. IR (ATR):
2233-2131, 1728, 1612 cm-1. HRMS: m/z calcd for C12H20D2O4N (M + H): 246.3227:
246.1669.
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(±)-7,7-Dideutero-1-oximinopyrrolizidine ((±)-7,7-[2H2]-10)

To the solution of diisopropylamine (2.18 mL, 21.5 mmol) in dry THF (85 mL) under
nitrogen at –78 C, n-BuLi (2.4 M in hexane) (7.5 mL) was added. The reaction mixture
was allowed to react for 1 h. A solution of ()-3,3-[2H2]-8 (2.21 g, 8.9 mmol) in THF (43
mL) was prepared and added to the above reaction mixture dropwise. The reaction mixture
was stirred at –78 C for 18 h and then brought to RT. H 2O (30 mL) was added to the
reaction mixture, and conc. HCl (30 mL) was added to it drop-by-drop at 0 ºC, followed
by 1.5 h reflux. The reaction mixture was adjusted to pH 9 by adding saturated solution of
K2CO3 in H2O at 0 C. NH4OH·HCl (0.62 g, 8.9 mmol) was added to the reaction mixture,
which was allowed to reflux for 2 h. The mixture was then stirred for 24 h. Solvent and
water were evaporated, and the crude compound was extracted with CH 2Cl2. The solvent
was concentrated, and the remainder was poured onto a silica column and then eluted with
CH2Cl2:CH3OH:NH4OH (8:2:0.2). Solvent was evaporated to yield ()-7,7-[2H2]-10 (0.6
g, 4.2 mmol, 47%) as a light brown powder and as an inseparable mixture of diastereomers.
3): δ 4.07 (s, 1H), 3.80 (s, 1H), 3.20 – 2.82 (m, 6H), 2.84 – 2.39

1H NMR (400 MHz, CDCl

(m, 6H), 1.94 – 1.68 (m, 4H). 2H NMR (61.5 MHz, CDCl3):  2.29 (broad s, 1H), 2.21
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(broad s, 1H), 1.88 (s, 1H), 1.75 (broad s, 1H). 13C NMR (100 MHz, CD3OD):  (major)
26.2, 30.3 (m, 20 Hz), 30.9, 51.7, 54.4, 64.4, 166.2;  (minor) 25.8, 30.2 (m, 20 Hz), 51.1,
54.2, 62.9, 165.8. IR (ATR): 3202, 2235-2125, 1842, 1675, 1509 cm-1. HRMS: m/z calcd
for C7H11D2N2O (M + H): 143.1148: 143.1149.

(±)-1-exo-7,7-Dideuteroacetamidopyrrolizidine ((±)-7,7-[2H2]-AcAP)

NaBH4 (0.19 g, 5.0 mmol) was added portionwise to a solution of (±)-7,7-[2H2]-10 (0.08
g, 0.5 mmol) and NiCl2 (0.21 g, 1.6 mmol) in anhydrous MeOH:THF (3:1, 5 mL) at –60
C over a period of 2 h (Caution: gas evolution!). After complete addition, the resulting
black slurry was allowed to warmed up to –30 °C and stirred at this temperature until no
more starting material was detected by TLC (18 h). Then, the reaction mixture was warmed
to room temperature, and Ac2O (in excess) was added with vigorous stirring. The
heterogeneous mixture was stirred for a further 4 h. Concentrated ammonium hydroxide
(10 mL) was added with stirring, and the mixture was filtered through a short pad of Celite.
The organic solvent was evaporated and extracted with DCM (3 times), and the combined
organic layers were washed with brine (2 times), dried over anhydrous MgSO4, and
concentrated in vacuo. The crude product was purified by flash chromatography, eluting
with CH2Cl2:CH3OH:NH4OH (6:4:0.2), to afford (±)-7,7-[2H2]-AcAP (13.2 mg, 0.078
mmol, 13%) as a gummy yellow solid. 1H NMR (400 MHz, CDCl3):  1.77 (m, 2H), 1.86
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(dq, Jd = 12.1 Hz, Jt = 6.0 Hz, 1H), 1.99 (s, 3H), 2.21 (dp, Jd = 13.0 Hz, Jp= 6.6 Hz, 1H),
2.66 (qd, Jd = 6.7 Hz, Jq = 9.8 Hz, 2H), 3.08 (dt, Jd = 10.7 Hz, Jt = 6.4 Hz, 1H), 3.41-3.22
(m, 2H), 4.15 (dtd, Jd = 6.7 Hz, Jd= 8 Hz, Jt = 5.1 Hz, 1H), 6.3 (broad s, 1H). 2H NMR
(61.5 MHz, CDCl3):  1.98 (broad s, 1H), 1.62 (broad s, 1H). 13C NMR (100 MHz,
CDCl3):  23.5, 25.3, 30.0 (m, 20 Hz), 32.8, 53.4, 55.2, 55.37, 70.9, 170.2. IR (ATR):
3233, 2233 (weak), 1659, 1541 cm-1. HRMS: m/z calcd for C9H15D2ON2 (M + H):
171.1461; found: 171.2597.
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Chapter 6. What is the stereochemical course of C-H bond oxidation by LolO?

Introduction
We have now shown that LolO abstracts an H atom from C(2) of AcAP first and
from C(7) second. It remains for us to elucidate the stereochemical course of the C–H bond
abstractions. We know, of course, that the new C–O bonds at both C(2) and C(7) form on
the endo face, but the C(2) radical that must precede C–O bond formation can be produced
by abstraction of either the endo or the exo H atom from C(2), and likewise from C(7)
(Scheme 6.1). In this chapter, we describe how we determined the stereochemical course
of H atom abstraction by LolO.

Scheme 6.1. Both exo and endo H atom abstraction in AcAP can allow for an endo bond
to the O atom.

We decided to investigate this question by feeding stereospecifically deuteriumlabeled precursors to loline-producing culture followed by GC–MS analysis of the extent
of deuterium enrichment of the produced NFL. From our groups’ previous work, we knew
that C(3) of L-proline became C(7) of NFL (Scheme 6.2).12 With the reasonable
assumption that the C(3) configuration of L-Pro would remain unchanged until the C–H
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abstraction event, we expected that feeding cis-3-[2H]-Pro would lead to the intermediate
7-exo-7-[2H]-AcAP, whereas feeding trans-3-[2H]-Pro would lead to the intermediate 7endo-7-[2H]-AcAP. Therefore, if LolO abstracted the endo H atom at C(7) of AcAP, then
feeding cis-3-[2H]-Pro would give 7-[2H]-NFL, whereas feeding trans-3-[2H]-Pro would
give NFL with no D atoms incorporated. By contrast, if LolO abstracted the exo H atom at
C(7) of AcAP, then feeding cis-3-[2H]-Pro would give NFL with no D atoms incorporated,
whereas feeding trans-3-[2H]-Pro would give 7-[2H]-NFL.

Scheme 6.2. Probing the stereochemistry of H atom abstraction from C(7) of AcAP using
deuterium-labeled L-proline.
Similarly, from our groups’ previous work, we knew that C(3) of L-Asp became
C(2) of NFL (Scheme 6.3).12 If we assumed that the C(3) configuration of L-Asp remained
unchanged until the C–H abstraction event, we expected that feeding (3R)-3-[2H]-Asp
would lead to the intermediate 2-exo-2-[2H]-AcAP, whereas feeding (3S)-3-[2H]-Asp
would lead to the intermediate 2-endo-2-[2H]-AcAP. Therefore, if LolO abstracted the
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endo H atom at C(2) of AcAP, then feeding (3R)-3-[2H]-Asp would give 2-[2H]-NFL,
whereas feeding (3S)-3-[2H]-Asp would give NFL with no D atoms incorporated. By
contrast, if LolO abstracted the exo H atom at C(2) of AcAP, then feeding (3R)-3-[2H]Asp would give NFL with no D atoms incorporated, whereas feeding (3S)-3-[2H]-Asp
would give 2-[2H]-NFL.

Scheme 6.3. Probing the stereochemistry of H atom abstraction from C(2) of AcAP using
deuterium-labeled L-Asp.

We hypothesize that LolO abstracts the endo H atom from both C(2) and C(7). The
Fe center in LolO almost certainly delivers the OH group to the endo face of C(2), so it is
likely that AcAP coordinates to the Fe center on its endo face. It then seems likely that the
abstraction of H atoms from both the C(2) and C(7) positions of AcAP occurs from the
endo face due to the proximity of the Fe center to the endo face of AcAP.

Results and discussion
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6.2.1. Synthesis of cis- and trans-3-[2H]-Pro
In order to study the stereochemistry of H atom abstraction at C(7) of AcAP, I
prepared regio- and stereospecifically deuterated prolines from trans-3-hydroxy-L-Pro
(28). Following the literature procedure,13 the N of proline derivative 28 was protected
with a Boc group, and the product was converted to its t-butyl ester (Scheme 6.4). The
product 29 was then divided into two portions. One portion was tosylated, reduced with
NaBD4, and deprotected with 6 M HCl to give cis-3-[2H]-Pro·HCl. The other portion of
29 was subjected to a Mitsunobu reaction to give 31, which was then tosylated, reduced
with NaBD4, and deprotected with 6 M HCl to give trans-3-[2H]-Pro·HCl.

Scheme 6.4. Synthetic routes to cis- and trans-3-[2H]-Pro·HCl.
6.2.2. Results of feeding experiments with cis- and trans-3-[2H]-Pro
Dr. Juan Pan fed cis-3-[2H]-Pro·HCl and trans-3-[2H]-Pro·HCl to cultures of E.
uncinata at 4 mM final concentrations. I extracted the cultures with CHCl3, and the
products were analyzed by GC–MS (Figure 6.1). The MS of undeuterated NFL has a
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prominent peak at 183 amu that is assigned as an [M + H] peak, plus a small peak at 184
amu due to a heavier isotope of C, N, or O. Incorporation of one D atom into NFL results
in an increase in the intensity of the peak at 184 amu (+1 amu). I found that NFL isolated
from the culture which was fed with cis-3-[2H]-Pro·HCl retained one D atom in NFL, as
shown by the large increase in the intensity of the 184 amu peak (Figure 6.1A), whereas
the culture fed with trans-3-[2H]-Pro·HCl showed only a small increase in the intensity of
the 184 amu peak (Figure 6.1B).
D H
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Figure 6.1. Mass spectrum showing NFL production in loline-producing culture from the
feeding of, (A) cis-3-[2H]-Pro·HCl; (B) trans-3-[2H]-Pro·HCl; (C) without any feeding.

I calculated the extent of incorporation of D in the two cases to be 30.5% and 2.9%,
respectively (Table 6.1). In both cases, the incorporation of D was significantly different
from control (Figure 6.1C; p = 0.04 and 0.03, respectively). I attribute the much smaller
2.9% incorporation from the feeding of trans-3-[2H]-Pro·HCl to contamination of this
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isomer with some cis-3-[2H]-Pro·HCl, as evident in the 1H NMR spectrum of trans-3[2H]-Pro·HCl (Figure 6.2).

Table 6.1. Relative deuterium incorporation from deuterated prolines in NFL. (a)
Significantly different from control (p = 0.03); (b) significantly different from controls (p
= 0.04).

Compounds

Conc.

Amu shift

% enrichment of 183 + 1 amu

(mM)

(183 + 1)

peak (mean ± SD)

cis-3-[2H]-Pro·HCl

4

+1

30.51 ± 2.26(a)

trans-3-[2H]-Pro·HCl

4

+1

2.93 ± 0.27(b)

H H

(A)

(S)

COOH

NH

H atom trans to
carboxylate group at C(3)

Pro

D H

(B)

(S)

(R)

NH

H D

(C)

(S)

(S)

H atom cis to carboxylate
group at C(3) is missing

COOH

cis-3-[2H]-Pro

H atom trans to
carboxylate group at C(3)

H atom cis to carboxylate
group at C(3)

COOH

NH
trans-3-[2H]-Pro

H atom cis to carboxylate
group at C(3)

H atom trans to carboxylate
group at C(3) as contaminant
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Figure 6.2. 1H NMR spectra showing contamination of trans-3-[2H]-Pro·HCl with cis-3[2H]-Pro·HCl. (A) Pro; (B) cis-3-[2H]-Pro·HCl; (C) trans-3-[2H]-Pro·HCl with small
amount of cis-3-[2H]-Pro·HCl as contaminant.

The strong incorporation of one D atom into the isolated NFL when fungal cultures
were fed with cis-3-[2H]-Pro·HCl suggested that LolO abstracted the endo hydrogen at the
C(7) position of AcAP during ether bridge formation, a conclusion that was consistent with
our original hypothesis (Scheme 6.5).

Scheme 6.5. Abstraction of endo H atom by LolO from C(7) of AcAP.
6.2.3. Synthesis of (3R)-(3-2H)-Asp and (3S)-(2,3-2H2)-Asp
To ascertain whether LolO abstracted the endo or exo H atom at C(2) of AcAP, I
prepared stereospecifically deuterium-labeled aspartic acids chemoenzymatically. I first
cloned, expressed, and purified the aspartate aminotransferase B (AspB) enzyme by
standard molecular biology tools.47 (an AspB-expression plasmid was kindly contributed
by Dr. M. Otzen from University of Groningen, Nijenborgh, Netherlands.) Following the
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literature procedure,48 I then added commercially available 2,3-[2H2]-fumaric acid to a
solution of AspB in aqueous NH4Cl, obtaining (3S)-2,3-[2H2]-Asp with 88.9%
dideuteration as measured by HRMS. Similarly, I added undeuterated fumaric acid to a
solution of AspB and ND4Cl in D2O, obtaining (3R)-3-[2H]-Asp with 94.5%
monodeuteration by HRMS (Scheme 6.6). (In this latter case, I used AspB that I had
purified in D2O buffer, because AspB purified in H2O buffer gave a much lower
incorporation of D into the final product.)

Scheme 6.6. Synthetic route to (3R)-3-[2H]-and (3S)-2,3-[2H2]-Asp.
6.2.4. Possible complications due to deuterium at the C(2) position of (3S)-2,3-[2H2]Asp
Due to the nature of our synthetic route to the (3S)-deuterated isotopomer of Asp, I
could not avoid introducing deuterium into its C(2) position. Unfortunately, the
incorporation of deuterium into the C(2) position led to complications in our ability to draw
conclusions from certain experimental outcomes. Specifically, multiple PLP enzymes in
the biosynthetic pathway might or might not exchange the C(2) D atom of (2S,3S)-2,3-
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[2H2]-Asp for an H atom (Scheme 6.7). If D–H exchange did not occur, then depending on
whether the endo or exo H at C(2) of AcAP was abstracted, I would obtain either [2H]NFL or [2H2]-NFL. On the other hand, if D–H exchange did occur, I would obtain either
undeuterated NFL or [2H]-NFL. Hence, if I obtained [2H]-NFL, then, without prior
knowledge of whether the C(2) D atom of (2S,3S)-2,3-[2H2]-Asp was involved in
exchange, it would have been difficult for us to determine whether LolO abstracted the
endo or exo H atom at C(2) of AcAP. We would revisit this after feeding experiments.

Scheme 6.7. Complications due to deuterium at C(2) position of (3S)-2,3-[2H2]-Asp.
6.2.5. Results of feeding experiments with (2S,3S)-3-[2H]-Asp and (2S,3S)-2,3-[2H2]Asp.
I fed (3R)-3-[2H]- and (3S)-2,3-[2H2]-Asp to loline-producing cultures separately
in triplicate. Table 6.2 shows the results of GC-MS analysis of the NFL obtained from the
feedings. The feedings of (3R)-3-[2H]-Asp gave NFL that was significantly more enriched
in one D atom than unfed control. By contrast, the feeding of (3S)-2,3-[2H2]-Asp gave NFL
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that was not significantly different from unfed control. The feeding of (3S)-2,3-[2H2]-Asp
gave essentially no [2H2]-NFL. These results led us to conclude that, (1) the C(2) D atom
was largely exchanged for H during the pathway leading up to AcAP, and (2) in support of
our original hypothesis, the endo H atom at the C(2) position of AcAP was abstracted by
LolO during ether bridge formation in the loline biosynthetic pathway (Scheme 6.10).

Table 6.2. Relative deuterium incorporation from deuterated aspartic acids in NFL (a)
Significantly different from control; (b) Not significantly different from control.

Compounds

Conc.
(mM)

Amu shift
(M + n)

% enrichment of
183 + Z amu
peak
(mean ± SD)

p value with
respect to
control

(3R)-3-[2H]-Asp

4

+1

4.1 ± 0.9

0.0029(a)

(3S)-2,3-[2H2]-Asp

4

+1

1.1 ± 0.4

0.9137(b)

(3S)-2,3-[2H2]-Asp

4

+2

0.2 ± 0.3

0.8139(b)

Earlier, I noted that our interpretation of the deuterated aspartic acids feeding results
depended on the reasonable assumption that the C(2) configuration of Asp was not altered
in the course of loline biosynthesis. Further reflection on the biosynthetic pathway,
however, has revealed to us that this assumption is incorrect. I know that Pro and Hse
(probably O-Ac-Hse) are the precursors to loline biosynthesis. We have previously shown
that Pro and O-Ac-Hse combine through a -substitution reaction to give the diamino diacid
N-(3-amino-3-carboxypropyl)proline (NACPP) (Scheme 1.5), and circumstantial evidence
suggests that LolC, a PLP enzyme, catalyzes this step.15 The mechanism of PLP-catalyzed
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-substitution reactions is as follows (Scheme 6.8): temporary conversion of the -amino
acid of O-Ac-Hse to an -imino acid, tautomerization to an enamine, and elimination of –
OAc to form an ,-unsaturated iminium ion. A nucleophile then reacts with the ,unsaturated iminium ion to produce a new enamine, which is then restored to the initial amino acid. During the formation of first enamine, LolC removes H+ from C(3) of Hse,
the very same position that I was deuterating in Asp in order to probe which H atom (exo
or endo) LolO abstracted from C(2) of AcAP.

Scheme 6.8. Proposed mechanism by which LolC and O-acetylhomoserine (thiol) lyase
catalyze -substitution reactions.
If LolC is catalyzing the combination of Pro and O-Ac-Hse through the above
mechanism, then the stereochemistry and the extent of D labelling installed at C(3) of (3R)and (3S)-3-[2H]-Asp is prone to change in numerous ways (Scheme 6.9). LolC showed
similarity to the -type PLP enzyme cystathionine -synthase.15 The mechanism proposed
for the cystathionine -synthase on the basis of crystal structure have same amino acid
removes and restores the C(3) H+.49 If LolC has similar active site as cystathionine synthase, then we can assume that LolC will restore H + or D+ to the same face of C(3)
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from which LolC removes it. Another complication though, is that the enzyme might
restore the same atom that it removed, or it might restore a different one. If the enzyme
removes the pro-R H+ or D+ and replaces it with a different H+ (Scheme 6.9A), it would
convert the R isotopolog to undeuterated, and it would preserve the configuration of the S
isotopolog. Similarly, if the enzyme removes the pro-S H+ or D+ and replaces it with a
different H+ (Scheme 6.9B), it would preserve the configuration of the R isotopolog, and
it would convert the S isotopolog to undeuterated.


Scheme 6.9. Effect of LolC on D atom content and configuration of Asps deuterated at
C(3). (A) LolC removes pro-R H/D, restores a different H+ to same face.; (B): LolC
removes pro-S H/D, restores a different H+ to same face.

With this analysis, we could predict the effect of six different scenarios on the
extent of deuteration of the NFL that we would obtain upon feeding our two Asp
isotopologs (Table 6.3). After matching the predicted results to the actual results from the
feeding experiments (Table 6.2), we hold to our original conclusion that LolO abstracts the
endo H atom from C(2) (Scheme 6.10).
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Table 6.3 Possible outcomes of feeding experiments of (3R)- and (3S)-3-[2H]-Asp after
LolC and LolO reactions. The first and third cells match the observed feeding results. (d1
denotes monodeuterated and d0 denotes undeuterated)
3-[2H]-Asp
configuration
at C3
R

H or D that
LolC removes
from C3
pro-R or pro-S

LolC
restores on
C3
same atom

Asp C3
after
LolC
R

NFL from
endo H
abstraction
d1

NFL from
exo H
abstraction
d0

S

pro-R or pro-S

same atom

S

d0

d1

R

pro-R

different H+

none

d0

d0

S

pro-R

different H+

S

d0

d1

R

pro-S

different H+

R

d1

d0

S

pro-S

different H+

none

d0

d0

Scheme 6.10. Abstraction of endo hydrogen atom by LolO from C(2) of AcAP.
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Conclusion
Our experiments support the hypotheses that LolO abstracts the endo H atoms from
the C(2) and C(7) positions of AcAP. This information is consistent with a mechanism
where AcAP binds to LolO in such a way that the catalytic Fe center resides on the endo
face of AcAP, and the Fe center is intimately involved in both the C–H abstractions and
the C–O bond formations leading to NANL.

Experimental Section
6.4.1. Synthesis of cis- and trans-3-[2H]-L-prolines
(2S,3S)-N-tert-Butoxycarbonyl-trans-3-hydroxyproline (29)

A 10% aqueous solution of NaOH (2.2 mL) was added to alcohol 28 (1.0 g, 7.6 mmol)
suspended in a mixture of THF/H2O (2:1, 10 mL). Di-tert-butyl dicarbonate (1.7 g, 7.6
mmol) was added, and the reaction mixture was stirred for 21 h at RT. The organic solvent
was evaporated, and the mixture pH was adjusted to 2 by addition of 10% aqueous KHSO 4
solution. The mixture was extracted with EtOAc, washed with brine, dried with MgSO 4,
and evaporated to give crude 29 (1.7 g, 7.5 mmol, 98% yield) as a yellow viscous oil. 1H
NMR (400 MHz, CDCl3) δ 1.43 (s, 9H; major), 1.47 (s, 9H; minor), 1.82–1.93 (m, 2H;
minor), 1.98–2.10 (m, 2H; major), 3.46–3.62 (m, 4H), 4.10 (br, 1H; major), 4.17 (br, 1H;
minor), 4.37-4.41 (m, 1H). 13C NMR (100 MHz, CDCl3) δ (major) 28.7, 33.0, 45.5, 69.6,
76.0, 81.6, 156.2, 174.5; δ (minor) 28.9, 33.6, 45.9, 69.3, 75.2, 81.5, 156.6, 174.2. IR
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(ATR): 3283, 1741, 1653 cm-1.

tert-Butyl (2S,3S)-N-tert-butoxycarbonyl-trans-3-hydroxy-L-proline (29)

Neat 34 (5.8 mL) was added to 33 (1.54 g, 6.67 mmol), and the mixture was stirred for 12
h at 80 ºC under nitrogen. The solution was cooled to RT, and H 2O (5.8 mL) was added.
The mixture was stirred for 22 h at RT. Saturated aqueous NaHCO3 (15 mL) was added,
and the mixture was extracted with Et2O. The organic layer was washed with water and
brine and dried with MgSO4. The crude compound was purified by flash chromatography
(5% MeOH in CH2Cl2) to give 29 (1.02 g, 3.55 mmol, 53% yield) as a yellow viscous oil.
1H NMR (400 MHz, CDCl ) δ 1.35 (s, 9H; major), 1.37 (s, 9H; minor), 1.38 (s, 9H; minor),
3

1.39 (s, 9H; major), 1.78–2.04 (m, 2H), 2.8 (br s, 1H; minor), 2.9 (br s, 1H; major), 3.44–
3.60 (m, 2 H), 4.02 (br s, 1H; major), 4.08 (br s, 1H; minor), 4.26–4.35 (m, 1H). 13C NMR
(100 MHz, CDCl3) δ (major) 27.8, 31.8, 44.2, 68.7, 74.7, 79.7, 81.2, 154.2, 170.3; δ
(minor) 28.2, 32.4, 44.5, 68.6, 73.7, 79.5, 81.4, 154.5, 170.2; IR (ATR): 3454, 3357, 1735,
1660 cm-1. HRMS: m/z calcd for C14H26NO5 (M + H): 288.3635: 288.1807.

tert-Butyl (2S,3R)-N- tert-Butoxycarbonyl-cis-3-deuteroprolinate (30)
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Triethylamine (1.45 mL, 10.4 mmol) was added to a mixture of alcohol 29 (0.3 g, 1 mmol)
and DMAP (0.13 g, 1.0 mmol) in dry CH2Cl2 (20 mL). TsCl (0.23 g, 1.2 mmol) was added
in portions over 1 h at 0 ºC, and the reaction mixture was stirred at 0 ºC for 54 h. A saturated
solution of NH4Cl was then added at 0 ºC, and the aqueous layer was extracted with
CH2Cl2. The combined organic extracts were washed with brine, dried with MgSO 4, and
evaporated. Silica gel chromatography (50% EtOAc in petroleum ether) afforded the
tosylate (0.36 g, 78% yield). The tosylate (0.36 g, 0.82 mmol) was dissolved in dry DMSO
(12 mL), and NaBD4 (0.21 g, 4.9 mmol) was added. The reaction mixture was heated to
95 ºC under nitrogen for 8 h. It was cooled and diluted with brine (effervescence), and the
aqueous phase was extracted with Et2O. The combined organic layers were dried over
MgSO4, and the solvent was evaporated. Flash chromatography (40% EtOAc in petroleum
ether) afforded 30 (0.185 g, 0.68 mmol, 83% yield) as a white gum. 1H NMR (400 MHz,
CDCl3) δ 1.38 (s, 9H), 1.40 (s, 9H), 1.68–1.94 (m, 2H), 2.01–2.18 (m, 1H), 3.12-3.55 (m,
2H), 4.04 (d, 8.6 Hz, 1H; major), 4.12 (d, 8.6 Hz, 1H; minor). 13C NMR (100 MHz, CDCl3)
δ (major) 23.4, 28.1, 28.5, 30.7 (t, 20.81 Hz), 46.4, 59.8, 79.7, 80.9, 154.1, 172.4; δ (minor)
23.2, 28.1, 28.5, 46.6, 59.7, 79.5, 154.4, 172.3. 2H NMR (61.5 MHz, CDCl3):  1.89 (broad
s, 1H). IR (neat): 1739, 1701 cm–1. HRMS [M]+: m/z calcd for C17H21D2NO4: 307.1747:
307.1744.
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cis-3-Deuteroproline·hydrochloride (cis-3-[2H]-Pro·HCl)

Compound 30 (185 mg, 0.680 mmol) was dissolved in 6 M HCl (7 mL), and the reaction
mixture was stirred for 2 h at RT. The water was evaporated to give cis-3-[2H]-Pro·HCl
(79 mg, 0.52 mmol, 87%) as a brown gum. 1H NMR (400 MHz, D2O) δ 2.01–2.12 (q, 7.1
Hz, 2H), 2.35-2.49 (m, 1H), 3.42 (qt, Jt = 7.3 Hz, Jq = 11.7 Hz, 2H), 4.43 (d, 8.8 Hz, 1H).
13C

NMR (100 MHz, D2O) δ 25.8, 30.5 (t, 20.4 Hz), 48.8, 62.1, 174.4. 2H NMR (61.5

MHz, D2O):  2.14 (broad s, 1H), 8.38 (broad s, 1H), 8.91 (broad s, 1H). IR (ATR): 3398,
2464, 1915, 1725 cm-1. EI-MS: Positive ion 116.9 amu ([M + H]), negative ion 35.1 amu
([Cl]).

tert-Butyl (2S,3R)-N-tert-butoxycarbonyl-cis-3-hydroxyproline (31)

DEAD (848 mg, 4.87 mmol) in dry THF (8 mL) was added to a solution of
triphenylphosphine (1.28 g, 4.87 mmol), benzoic acid (0.59 g, 4.9 mmol), and 29 (700 mg,
2.44 mmol) in dry THF (20 mL) at 0 ºC under nitrogen. The reaction mixture was stirred
for 5 min at 0 ºC, and then for 22 h at RT. The solvent was evaporated, the residue was
suspended in methanolic KOH solution (1.0 M, 43 mL) at 0 ºC, and the mixture was stirred
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for 30 min. The solvent was evaporated, and the residue was partitioned between EtOAc
and water. The organic layer was washed with brine, dried with MgSO 4, and evaporated.
Flash chromatography (30% acetone in petroleum ether) afforded 31 (624 mg, 2.17 mmol,
89% over two steps) as a white solid. 1H NMR (400 MHz, CDCl3) δ 1.35 (s, 9H; major),
1.37 (s, 9H; minor), 1.39 (s, 9H; minor), 1.40 (s, 9H; major), 1.86–2.06 (m, 2H), 3.23–3.41
(m, 1H), 3.44–3.61 (m, 1H), 4.12 (d, 7.0 Hz, 1H; major), 4.15 (d, 7.0 Hz, 1H; minor), 4.30–
4.40 (p, 6.6 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ (major) 28.0, 28.1, 31.7, 43.6, 64.0,
71.9, 79.7, 81.1, 154.0, 169.5; δ (minor) 27.9, 28.2, 32.2, 44.0, 63.8, 71.0, 79.5, 81.2, 154.2,
169.6. IR (ATR): 3240, 2162, 1740, 1693 cm-1. HRMS: m/z calcd for C14H26NO5 (M +
H): 288.3635: 288.1807.

tert-Butyl (2S,3S)-N-tert-butoxycarbonyl-trans-3-deuteroprolinate (32)

Triethylamine (3.0 mL, 22 mmol) was added to a mixture of alcohol 31 (624 mg, 2.17
mmol) and DMAP (0.265 g, 2.17 mmol) in dry CH2Cl2 (40 mL). TsCl (0.50 g, 2.6 mmol)
was added in portions over 1 h at 0 ºC, and the reaction mixture was stirred at 0 ºC for 54
h. A saturated solution of NH4Cl was added at 0 ºC, and the aqueous layer was extracted
with CH2Cl2. The combined organic extracts were washed with brine, dried with MgSO 4,
and evaporated. Silica gel chromatography (50% EtOAc in petroleum ether) afforded the
tosylate (959 mg, 2.17 mmol, 57% yield). The tosylate (549 mg, 1.24 mmol) was dissolved
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in dry DMSO (20 mL), and NaBD4 (260 mg, 6.22 mmol) was added to it. The reaction
mixture was heated to 95 ºC under nitrogen for 8 h. It was cooled and diluted with brine
(effervescence), and the aqueous phase was extracted with Et 2O. The combined organic
layers were dried over MgSO4, and the solvent was evaporated. Flash chromatography
(40% EtOAc in petroleum ether) afforded 32 (256 mg, 0.941 mmol 75%) as a white gum.
1H

NMR (400 MHz, CDCl3) δ 1.36 (s, 9H), 1.39 (s, 9H), 1.68–1.92 (m, 3H), 2.01–2.18

(m, 1H), 3.19-3.55 (m, 2H), 4.03 (s, 1H; major), 4.11 (s, 1H; minor). 13C NMR (100 MHz,
CDCl3) δ (major) 23.4, 28.1, 28.5, 30.7 (t, 20.3 Hz), 46.4, 59.7, 79.7, 80.9, 154.1, 172.4; δ
(minor) 24.2, 28.1, 28.5, 29.7 (t, 20.7 Hz), 46.6, 59.7, 79.5, 154.4, 172.4. 2H NMR (61.5
MHz, CDCl3):  2.14 (broad s, 1H); IR (neat): 1738, 1689 cm-1. HRMS [M]+: m/z calcd
for C17H21D2NO4: 307.1747: 307.1744.

trans-3-Deuteroproline hydrochloride (trans-3-[2H]-Pro·HCl)

Compound 32 (256 mg, 0.340 mmol) was dissolved in 6 M HCl (7.5 mL), and the reaction
mixture was stirred for 2 h at RT. The water was evaporated to give trans-3-[2H]-Pro·HCl
(107 mg, 0.704 mol, 98%) as a brown gum. 1H NMR (400 MHz, D2O) δ 2.00–2.25 (m,
3H), 3.36–3.53 (m, 2 H), 4.44 (d, 7.0 Hz, 1H). 13C NMR (100 MHz, D2O) δ 25.8, 30.6 (t,
22 Hz), 48.7, 62.1, 174.5. 2H NMR (61.5 MHz, D2O):  2.39 (broad s, 1H), 8.35 (broad s,
1H), 8.88 (broad s, 1H). IR (ATR): 3355, 2165-2066, 1736 cm-1. EI-MS: Positive ion 116.9
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amu ([M + H]), negative ion 35.1 amu ([Cl]).

6.4.2. Transformation, expression and purification of AspB-His6 enzyme
The procedure for transformation, expression and purification of AspB-His6 was
performed as reported by B. Feringa, D. B. Janssen, G. J. Poelarends et al. with
modification.47
6.4.2.1. Transformation and expression
The AspB-His6 plasmid (with pBAD expression system) was transformed into Top10 cells,
plated on a LB plate with ampicillin antibiotics, and incubated overnight at 37 ºC. A colony
of Top10 cells containing AspB-His6 plasmid was collected using a pipette tip and used to
inoculate 5 mL LB medium (with ampicillin) in a 14 mL Falcon tube with loose cap. (We
used 100 μL of ampicillin (100 mg/ml) for 100 mL LB.) The mixture was incubated in a
shaker overnight at 37 ºC at 180 rpm. The tube was removed from incubator and poured
into 500 mL LB with ampicillin and incubated at 37 ºC, 180 rpm. Optical density at 600
nm with UV/Vis was measured until it reached 0.7-0.8. Thereafter, the culture was induced
with sterile arabinose solution (final concentration 0.08%) and incubated in a shaker
overnight at 37 ºC at 180 rpm. The cells were centrifuged at 4000 rpm and 4 °C for 15 min
using a JA-25-50 rotor. The LB was decanted, and the cell pellet was transferred into a 50
mL Falcon tube and suspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM
imidazole, pH 8.0) in an ice bath. The cells were disrupted by sonicating in Branson 250
microtip for 3  1 min with 3 min rest in between each cycle (60 W output). The lysate was
centrifuged for 30 min at 17,000 g at 4 °C using JA-25-50 rotor to remove cell debris. The
protein was in the supernatant, which was collected into a 15 mL tube.
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6.4.2.2. Purification with Ni NTA agarose
All the steps in the AspB-His6 purification were done at 4 °C. The Ni NTA agarose solution
(4 fractions of 1 mL) was equilibrated 3 times with lysis buffer. The 1 mL lysate solution
was added to each fraction and incubated at 4 °C for 30 min under rotation in an end-overend rotor. The column was washed three times with buffer A (50 mM NaH2PO4, 300 mM
NaCl, 20 mM imidazole, pH 8.0; 0.5 mL/column). The AspB-His6 protein was eluted from
the column by using buffer B (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH
8.0; 0.25 mL/column). The purified protein was passed through PD-10 column using 50
mM equilibrating phosphate buffer (pH 8). The fractions were concentrated in a centrifugal
concentrator with 30 kDa molecular weight cut-off (Pall Corporation, Port Washington,
NY), and the absorbance of the protein was measured at 280 nm. The protein was diluted
with sterile 10% glycerol and stored at –80 ºC until further use.

6.4.3. Synthesis of deuterium-labeled aspartic acids
(2S,3S)-2,3-Dideutero-L-aspartic acid ((2S,3S)-2,3-[2H2]-Asp)

2,3-Dideuterofumaric acid (0.50 g, 4.2 mmol) was suspended in water (4 mL), the pH was
adjusted to 9 with aqueous NH4OH, and MgCl2·6H2O (0.516 mg, 2.54 mmol) and KCl
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(44 mg, 1.1 mmol) were added. The pH was again adjusted to 9 with aqueous ammonia
hydroxide, and AspB enzyme was added. The reaction mixture was incubated at 25 °C for
72 h. The solution was heated at 100 ºC for 2 min and then filtered through Celite. The
filtrate pH was reduced to 1 with 12 M HCl and extracted with Et2O (2 times). The aqueous
layer was adjusted to pH 4, and EtOH was added to precipitate the aspartic acid. Filtration
gave (2S,3S)-2,3-[2H2]-Asp as a white solid (0.41 g, 3.0 mmol, 68%). 1H NMR (400 MHz,
D2O) δ 3.10 (s, 1H). 2H NMR (61.5 MHz, D2O):  2.14 (broad s, 1H), 2.41 (broad s, 1H).
13C

NMR (100 MHz, D2O) δ 34.5 (t, 20 Hz), 50.7 (t, 21.4 Hz), 173.0, 174.6. IR (ATR):

2165-2076, 1685, 1639 cm-1. HRMS: m/z calcd for C4H6D2NO4 (M + H): 136.1227:
136.0575.

(3R)-3-deutero-L-aspartic acid ((3R)-3-[2H]-Asp)

Fumaric acid (0.5.0 g, 4.3 mmol) was suspended in D2O (20 mL), the pH was adjusted to
9 with ND4OH in D2O, and MgCl2.6H2O (525 mg, 2.58 mmol) and KCl (44.7 mg, 1.15
mmol) were added. The pH was again adjusted to 9 with ND 4OH in D2O, and AspB
enzyme (purified in D2O buffer) was added. The reaction mixture was incubated at 25 °C
for 72 h. The solution was heated to 100 ºC for 2 min and then filtered through Celite. The
filtrate pH was reduced to 1 with 12 M HCl and extracted with Et2O (2 times). The aqueous
layer was adjusted to pH 4, and EtOH was added to precipitate the aspartic acid. Filtration
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gave (3R)-3-[2H]-Asp as white solid (213 mg, 1.59 mmol, 48%). 1H NMR (400 MHz,
D2O) δ 2.94 (d, 7.5 Hz, 1H), 4.06 (d, 7.58 Hz, 1H). 2H NMR (61.5 MHz, D2O):  2.86
(broad s, 1H). 13C NMR (100 MHz, D2O) δ 34.5 (t, 20.2 Hz), 50.8, 173.0, 174.6. IR (ATR):
2231-2078, 1684, 1639 cm-1. HRMS: m/z calcd for C4H7DNO4 (M + H): 135.1166:
135.0512.

6.4.4. Fungal isolation from infected plant (e167)
The procedure for fungal (Neotyphodium uncinatum) isolation was same as reported in our
groups’ previous work.11 Leaf blades from the grasses (number 167 from the plant
collection) were collected from the greenhouse. They were cleaned and washed three times
with autoclaved water in a 50 mL Falcon tube to remove any soil. They were sterilized by
washing with 95% ethanol for 10 sec, followed by rinsing with autoclaved water. They
were soaked in 50% bleach for 30 min, with shaking every 10 min. The bleach was slowly
poured into the waste container, and each tube was washed three times with autoclaved
water. The leaf blades were cut into 2-mm sections and plated on PDA plates with penicillin
(350 uL) and streptomycin (350 uL) using sterilized forceps. They were incubated at 22 ºC
for two weeks with frequent checking for unknown growth. After 2 weeks, fungal
mycelium was removed with a sterile blade, homogenized in sterile water with a sterile
stick, and drop-inoculated on an antibiotic-free PDA plate. In order to have fresh fungus,
it was subcultured every 7-10 days.

6.4.5. Preparation of minimal media for the culture of fungus
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Minimal media was prepared as reported in our groups’ previous work.11 A basal salt
solution of pH 5.5 was made by mixing K2HPO4 (1.369 g) and KH2PO4 (4.083 g) in 100
mL of Milli-Q water. MOPS (5.856 g) was then added, the pH was adjusted to 5.5 with
NaOH, and the solution was autoclaved. MgSO4 (2mM, 0.493 g) was dissolved in 100 mL
of Milli-Q water and autoclaved separately to prevent precipitation of salts. A solution of
thiamine (0.6 mL of 0.6 mM) and a solution of 1 mL of trace elements to give 3.6 mM
H3BO3, 1 mM CuSO4, 0.7 mM KI, 0.8 mM FeNa- ethylenediaminetetraacetic acid, 1 mM
MnSO4, 0.5 mM NaMoO4, and 0.4 mM ZnSO4 was added to 116.7 mL solution of sucrose
(20 mM, 6.846 g) and urea (15 mM, 0.900 g) in Milli-Q water. This solution was filtered
sterilely. Basal salts at pH 5.5 and MgSO4 were mixed together and added to the sterile
solution of thiamine, trace elements, sucrose, and urea. The volume was made to 1 L by
adding autoclaved Milli-Q water. The final concentration of the phosphate buffer and
MOPS were 30 mM.

6.4.6. Feeding deuterated Asp to fungal culture and sampling from cultures
Fungal culture in minimal media was prepared as reported in our groups’ previous work.13
The fungal mycelium was removed with a sterile blade from the PDA plate and
homogenized in sterile water using a sterile stick. The fungal inoculum (250 uL/plate) was
added into the 15 mL minimal media in 18 polystyrene petri plates (60  15 mm). The
cultures were incubated in rotary shaker at 22 ºC at 70 rpm. Sterile solutions of (2S,3S)-3[2H]-Asp, (2S,3S)-2,3-[2H2]-Asp, and (2S)-2,2,3-[2H3]-Asp were prepared in Milli-Q
water and fed to loline-producing cultures separately in triplicate on the 6th day of growth.
The cultures (1.7 mL) were harvested on the 16th day and lyophilized. The lyophilized
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samples were basified using NaOH (1 M, 100 μL) and diluted using CHCl3 (1 mL). The
mixture was vortexed, shaked at room temperature at 130 rpm for 1 h, and centrifuged at
13000 rpm for 15 min. The chloroform layer was separated and filtered into a GC-MS vial.
The samples were analyzed through GC-MS to measure deuterium incorporation.
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Chapter 7. Conclusions and future directions

My investigation of ether bridge formation in loline alkaloid biosynthesis started
when Dr. Juan Pan isolated AcAP, a novel metabolite, from fungi that had a mutated lolO
gene due to RNAi. I synthesized an authentic sample of (±)-AcAP, demonstrated its
structure and stereochemistry, and showed its spectroscopic identity with AcAP isolated
from a lolO mutant.
In order to determine whether AcAP was an intermediate or a shunt product, I
synthesized 2´,2´,2´,3-[2H4]-AcAP. Through feeding of 2´,2´,2´,3-[2H4]-AcAP to fungal
cultures, Dr. Juan Pan established that AcAP is an intermediate in the loline alkaloid
biosynthesis, not a shunt product. This finding let us establish AcAP as the LolO substrate
and NANL as the first loline produced in loline alkaloid biosynthesis.
However, this experiment did not explain what was the product of LolO-catalyzed
oxidation of AcAP, and whether LolO alone, or in combination with other enzymes,
installed the ether bridge in AcAP. Through the feeding of (±)-AcAP to yeast modified
with the lolO gene, Dr. Juan Pan established that NANL is the product of LolO oxidation
of AcAP. This result implied that LolO catalyzed two C–H activations of AcAP and both
C–O bond-forming reactions during the formation of the ether bridge in NANL, a very
unusual transformation. In addition, initial work by Dr. Wei-chen Chang further confirmed
this finding through the feeding of AcAP to purified LolO enzyme. He also observed a
hydroxylated product of AcAP, a previously unknown metabolite.
In order to resolve whether initial hydroxylation of AcAP catalyzed by LolO
occurred at C(2) or C(7), I synthesized (±)-7,7-[2H2]- and (±)-2,2,8-[2H3]-AcAP. Dr. Juan
Pan subjected (±)-AcAP, (±)-7,7-[2H2]-, and (±)-2,2,8-[2H3]-AcAP to the LolO oxidation
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reaction under single-oxidation conditions. She observed a very large KIE in the case of
(±)-2,2,8-[2H3]-AcAP only, demonstrating that LolO abstracted the C(2) H atom first to
produce 2-hydroxy-AcAP. Further support for the structure of 2-hydroxy-AcAP was
obtained upon its isolation by Dr. Juan Pan. I used the isolated material to establish the
structure and stereochemistry of 2-endo-2-hydroxy-AcAP by NMR.
Next, I wanted to investigate the stereochemical course of C–H bond abstraction
(exo or endo) by LolO from C(2) and C(7) of AcAP. In order to do this, I synthesized transand cis-3-[2H]-Pro and (2S,3R)-3-[2H]- and (2S,3S)-2,3-[2H2]-Asp. Feedings to lolineproducing cultures conducted by both Dr. Juan Pan (Pro) and me (Asp) showed that the
endo H atom was abstracted from both the C(2) and C(7) positions of AcAP en route to
ether bridge formation in loline alkaloid biosynthesis (Scheme 1.4).
In summary, I was able to investigate the ether bridge formation with the help of
our collaborators. There are still many unanswered questions remaining regarding the
biosynthesis of the loline alkaloids. Dr. Wei-chen Chang observed that LolO seems to be
consuming its unnatural enantiomer (Figure 4.2), so in a future study, one could study the
ability of LolO to oxidize a range of substrates. To better understand the structure of LolO,
X-ray crystallization of LolO with AcAP would be helpful.
To understand the kinetics and mechanism of the second C–H activation event
catalyzed by LolO, one could isolate more 7,7-[2H2]-2-hydroxy-AcAP and subject it to
LolO oxidation again. Alternatively, one could synthesize 7,7-[2H2]-2-endo-2-hydroxyAcAP to accomplish the same goal. One could also study the crystal structure of (±)-AcAP
and try to understand why the crystal I was able to grow had such an unusual structure
(Figure 2.18).
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With all my heart, I wish very well for all future researchers and graduate students
who would be working to answer all the above questions and any other questions which
may arise.
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Appendix

Figure A.1. HRMS of ()-AcAP
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Figure A.2. 1H–13C HMBC of ()-AcAP
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Figure A.3. HRMS of (±)1-epi-AcAP
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Figure A.4. 1HNMR of equimolar mixture of synthetic and isolated AcAP.
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Figure A.5. 13C NMR of equimolar mixture of synthetic and isolated AcAP.
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Figure A.6. GC-MS of equimolar mixture of synthetic and isolated AcAP.

109

Table A.1: Crystal data and structure refinement for ()-AcAP

Empirical formula

C18 H33 Cl N4 O2

Formula weight

372.93

Temperature

90.0(2) K

Wavelength (Å)

1.54178 A

Crystal system, space group

Monoclinic,

space group

C2/c

Unit cell dimensions
A (Å)

20.2461(7)

 (°)

90

B (Å)

9.7027(4)

 (°)

100.562(2)

c (Å)

10.1617(4)

 (°)

90

Volume (Å3)

1962.36(13)

Z

4

Calculated density (Mg/m3 )

1.262

Absorption coefficient (mm-1)

1.871

F (000)

808

Crystal size (mm)

0.230 x 0.060 x 0.020

 range for data collection (°)

4.443 to 68.364

Limiting indices

-23<=h<=24,
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-11<=k<=11
-12<=l<=5
Reflections collected / unique

12509 / 1788
[R(int) = 0.0481]

Completeness to  = 67.679

99.4 %

Absorption correction

Semi-empirical from equivalents

Max. transmission

0.971

Min. transmission

0.754

Refinement method

Full-matrix least-squares on F2

Data/restraints/parameters

1788 / 36 / 129

Goodness-of-fit on F2

1.068

Final R indices [I>2sigma(I)]

R1 = 0.0486,
R2 = 0.1416

R indices (all data)

R1 = 0.0500,
R2 = 0.1429

Extinction coefficient

0.0010(3)

Largest diff. peak and hole e.A-3

0.823 and -0.207
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Table A.2: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters
(Å2 x 103) for ()-AcAP. U(eq) is defined as one third of the trace of the orthogonalized
Uij tensor.
x

y

z

U(eq)

N (1)

5656(1)

7822(2)

2630(2)

30 (1)

N (2)

6412(1)

4380(2)

2918(2)

29 (1)

O (1)

7544(1)

4168(2)

3213(2)

38 (1)

C (2)

6379(1)

5838(2)

2612(2)

29 (1)

C (3)

6025(1)

6176(2)

1188(2)

35 (1)

C (4)

5866(1)

7688(2)

1289(2)

35 (1)

C (5)

5893(1)

9118(2)

3362(2)

39 (1)

C (6)

6528(1)

8708(3)

4313(2)

35 (1)

C (7)

6349(2)

7273(3)

4772(3)

32 (1)

C (1)

5966(1)

6628(2)

3485(2)

29 (1)

C (5´)

5893(1)

9118(2)

3362(2)

39 (1)

C (6´)

6152(12)

8737(18)

4740(16)

35 (1)

C (7´)

6506(11)

7370(20)

4530(30)

32 (1)

C (1´)

5966(1)

6628(2)

3485(2)

29 (1)

C (8)

6984(1)

3651(2)

3160(2)

28 (1)

C (9)

6890(1)

2136(2)

3372(2)

34 (1)

C (1)

5000

2720(1)

2500

31 (1)
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Table A.3: Bond lengths [Å] and angles [°] for ()-AcAP.

N(1)-C(5')

1.494(3)

N(1)-C(5)

1.494(3)

N(1)-C(4)

1.505(3)

N(1)-C(1')

1.512(3)

N(1)-C(1)

1.512(3)

N(1)-H(1N)

1.3114(19)

N(2)-C(8)

1.341(3)

N(2)-C(2)

1.447(3)

N(2)-H(2N)

0.95(3)

O(1)-C(8)

1.233(3)

C(2)-C(3)

1.528(3)

C(2)-C(1')

1.532(3)

C(2)-C(1)

1.532(3)

C(2)-H(2)

1.0000

C(3)-C(4)

1.510(3)

C(3)-H(3A)

0.9900

C(3)-H(3B)

0.9900

C(4)-H(4A)

0.9900

C(4)-H(4B)

0.9900

C(5)-C(6)

1.513(3)

C(5)-H(5A)

0.9900
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C(5)-H(5B)

0.9900

C(6)-C(7)

1.532(3)

C(6)-H(6A)

0.9900

C(6)-H(6B)

0.9900

C(7)-C(1)

1.528(3)

C(7)-H(7A)

0.9900

C(7)-H(7B)

0.9900

C(1)-H(1)

1.0000

C(5')-C(6')

1.450(15)

C(5')-H(5'1)

0.9900

C(5')-H(5'2)

0.9900

C(6')-C(7')

1.543(18)

C(6')-H(6'1)

0.9900

C(6')-H(6'2)

0.9900

C(7')-C(1')

1.554(17)

C(7')-H(7'1)

0.9900

C(7')-H(7'2)

0.9900

C(1')-H(1')

1.0000

C(8)-C(9)

1.503(3)

C(9)-H(9A)

0.9800

C(9)-H(9B)

0.9800

C(9)-H(9C)

0.9800
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C(5')-N(1)-C(4)

113.95(18)

C(5)-N(1)-C(4)

113.95(18)

C(5')-N(1)-C(1')

107.33(16)

C(4)-N(1)-C(1')

107.33(16)

C(5)-N(1)-C(1)

107.33(16)

C(4)-N(1)-C(1)

107.33(16)

C(5')-N(1)-H(1N)

105.8(17)

C(5)-N(1)-H(1N)

105.8(17)

C(4)-N(1)-H(1N)

110.9(2)

C(1')-N(1)-H(1N)

111.5(16)

C(1)-N(1)-H(1N)

111.5(16)

C(8)-N(2)-C(2)

123.97(18)

C(8)-N(2)-H(2N)

117.8(18)

C(2)-N(2)-H(2N)

118.1(18)

N(2)-C(2)-C(3)

114.07(18)

N(2)-C(2)-C(1')

111.90(16)

C(3)-C(2)-C(1')

103.25(17)

N(2)-C(2)-C(1)

111.90(16)

C(3)-C(2)-C(1)

103.25(17)

N(2)-C(2)-H(2)

109.1

C(3)-C(2)-H(2)

109.1

C(1)-C(2)-H(2)

109.1

C(4)-C(3)-C(2)

102.31(17)
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C(4)-C(3)-H(3A)

111.3

C(2)-C(3)-H(3A)

111.3

C(4)-C(3)-H(3B)

111.3

C(2)-C(3)-H(3B)

111.3

H(3A)-C(3)-H(3B)

109.2

N(1)-C(4)-C(3)

104.14(17)

N(1)-C(4)-H(4A)

110.9

C(3)-C(4)-H(4A)

110.9

N(1)-C(4)-H(4B)

110.9

C(3)-C(4)-H(4B)

110.9

H(4A)-C(4)-H(4B)

108.9

N(1)-C(5)-C(6)

104.66(18)

N(1)-C(5)-H(5A)

110.8

C(6)-C(5)-H(5A)

110.8

N(1)-C(5)-H(5B)

110.8

C(6)-C(5)-H(5B)

110.8

H(5A)-C(5)-H(5B)

108.9

C(5)-C(6)-C(7)

102.3(2)

C(5)-C(6)-H(6A)

111.3

C(7)-C(6)-H(6A)

111.3

C(5)-C(6)-H(6B)

111.3

C(7)-C(6)-H(6B)

111.3

H(6A)-C(6)-H(6B)

109.2
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C(1)-C(7)-C(6)

102.86(19)

C(1)-C(7)-H(7A)

111.2

C(6)-C(7)-H(7A)

111.2

C(1)-C(7)-H(7B)

111.2

C(6)-C(7)-H(7B)

111.2

H(7A)-C(7)-H(7B)

109.1

N(1)-C(1)-C(7)

105.65(17)

N(1)-C(1)-C(2)

105.27(16)

C(7)-C(1)-C(2)

117.05(19)

N(1)-C(1)-H(1)

109.5

C(7)-C(1)-H(1)

109.5

C(2)-C(1)-H(1)

109.5

C(6')-C(5')-N(1)

107.0(7)

C(6')-C(5')-H(5'1)

110.3

N(1)-C(5')-H(5'1)

110.3

C(6')-C(5')-H(5'2)

110.3

N(1)-C(5')-H(5'2)

110.3

H(5'1)-C(5')-H(5'2)

108.6

C(5')-C(6')-C(7')

100.4(14)

C(5')-C(6')-H(6'1)

111.7

C(7')-C(6')-H(6'1)

111.7

C(5')-C(6')-H(6'2)

111.7

C(7')-C(6')-H(6'2)

111.7
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H(6'1)-C(6')-H(6'2)

109.5

C(6')-C(7')-C(1')

101.8(13)

C(6')-C(7')-H(7'1)

111.4

C(1')-C(7')-H(7'1)

111.4

C(6')-C(7')-H(7'2)

111.4

C(1')-C(7')-H(7'2)

111.4

H(7'1)-C(7')-H(7'2)

109.3

N(1)-C(1')-C(2)

105.27(16)

N(1)-C(1')-C(7')

101.8(9)

C(2)-C(1')-C(7')

103.6(10)

N(1)-C(1')-H(1')

114.9

C(2)-C(1')-H(1')

114.9

C(7')-C(1')-H(1')

114.9

O(1)-C(8)-N(2)

123.4(2)

O(1)-C(8)-C(9)

122.1(2)

N(2)-C(8)-C(9)

114.51(19)

C(8)-C(9)-H(9A)

109.5

C(8)-C(9)-H(9B)

109.5

H(9A)-C(9)-H(9B)

109.5

C(8)-C(9)-H(9C)

109.5

H(9A)-C(9)-H(9C)

109.5

H(9B)-C(9)-H(9C)

109.5
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Table A.4: Anisotropic displacement parameters (Å2 x 103) for ()-AcAP. The anisotropic
displacement factor exponent takes the form: -2 π2 [h2 a*2 U11 + ... + 2 h k a* b* U12]

U11

U22

U33

N (1)

34 (1)

25 (1)

30 (1)

1 (1)

2 (1)

–2 (1)

N (2)

29 (1)

27 (1)

32 (1)

0 (1)

7 (1)

–2 (1)

O (1)

31 (1)

38 (1)

44 (1)

5 (1)

4 (1)

–1 (1)

C (2)

30 (1)

28 (1)

30 (1)

2 (1)

6 (1)

–2 (1)

C (3)

40 (1)

38 (1)

27 (1)

2 (1)

9 (1)

–2 (1)

C (4)

38 (1)

37 (1)

30 (1)

6 (1)

5 (1)

–2 (1)

C (5)

43 (1)

27 (1)

42 (1)

–2 (1)

– 3 (1)

–4 (1)

C (6)

38 (2)

34 (1)

31 (1)

–3 (1)

0 (1)

–7 (1)

C (7)

35 (2)

34 (1)

26 (1)

–1 (1)

4 (1)

0 (1)

C (1)

30 (1)

29 (1)

26 (1)

1 (1)

2 (1)

0 (1)

C (5´)

43 (1)

27 (1)

42 (1)

– 2 (1)

–3 (1)

–4 (1)

C (6´)

38 (2)

34 (1)

31 (1)

–3 (1)

0 (1)

–7 (1)

C (7´)

35 (2)

34 (1)

26 (1)

–1 (1)

4 (1)

0 (1)

C (1´)

30 (1)

29 (1)

26 (1)

1 (1)

2 (1)

0 (1)

C (8)

31 (1)

32 (1)

21 (1)

–2 (1)

5 (1)

–1 (1)

C (9)

39 (1)

29 (1)

31 (1)

–1 (1)

3 (1)

1 (1)

C (1)

18 (1)

29 (1)

44 (1)

1 (1)

0
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U23

0

U13

U12

Table A.5: Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x
103) for ()-AcAP.

x

y

z

U (eq)

H (1N)

5000

7830(50)

2500

64(13)

H (2N)

6000 (15)

3900(30)

2880(30)

51(8)

H (2)

6845

6223

2759

35

H (3A)

6324

6015

534

42

H (3B)

5611

5623

929

42

H (4A)

6266

8262

1249

42

H (4B)

5497

7968

558

42

H (5A)

5551

9470

3861

47

H (5B)

5988

9839

2733

47

H (6A)

6629

9355

5077

42

H (6B)

6917

8669

3850

42

H (7A)

6758

6737

5133

38

H (7B)

6063

7336

5464

38

H (1)

5601

6019

3700

34

H (5´1)

6249

9558

2959

47

H (5´2)

5516

9777

3319

47

H (6´1)

5786

8600

5253

42

H (6´2)

6472

9431

5197

42
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H (7´1)
H (7´2)

6613
6923

6834
7528

5372
4175

38
38

H (1´)

5639

6053

3874

34

H (9A)

7025

1617

2636

50

H (9B)

6417

1950

3396

50

H (9C)

7169

1853

4222

50
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Table A 6: Torsion angles [°] for ()-AcAP.

C(8)-N(2)-C(2)-C(3)

113.2(2)

C(8)-N(2)-C(2)-C(1')

-130.07(19)

C(8)-N(2)-C(2)-C(1)

-130.07(19)

N(2)-C(2)-C(3)-C(4)

162.39(18)

C(1')-C(2)-C(3)-C(4)

40.7(2)

C(1)-C(2)-C(3)-C(4)

40.7(2)

C(5')-N(1)-C(4)-C(3)

142.14(19)

C(5)-N(1)-C(4)-C(3)

142.14(19)

C(1')-N(1)-C(4)-C(3)

23.4(2)

C(1)-N(1)-C(4)-C(3)

23.4(2)

C(2)-C(3)-C(4)-N(1)

-39.6(2)

C(4)-N(1)-C(5)-C(6)

-96.9(2)

C(1)-N(1)-C(5)-C(6)

21.9(2)

N(1)-C(5)-C(6)-C(7)

-38.6(2)

C(5)-C(6)-C(7)-C(1)

40.4(3)

C(5)-N(1)-C(1)-C(7)

3.7(2)

C(4)-N(1)-C(1)-C(7)

126.6(2)

C(5)-N(1)-C(1)-C(2)

-120.81(19)

C(4)-N(1)-C(1)-C(2)

2.1(2)

C(6)-C(7)-C(1)-N(1)

-27.3(3)

C(6)-C(7)-C(1)-C(2)

89.5(2)

N(2)-C(2)-C(1)-N(1)

-149.51(17)
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C(3)-C(2)-C(1)-N(1)

-26.4(2)

N(2)-C(2)-C(1)-C(7)

93.5(2)

C(3)-C(2)-C(1)-C(7)

-143.4(2)

C(4)-N(1)-C(5')-C(6')

-135.3(10)

C(1')-N(1)-C(5')-C(6')

-16.6(10)

N(1)-C(5')-C(6')-C(7')

38.9(17)

C(5')-C(6')-C(7')-C(1')

-46(2)

C(5')-N(1)-C(1')-C(2)

-120.81(19)

C(4)-N(1)-C(1')-C(2)

2.1(2)

C(5')-N(1)-C(1')-C(7')

-13.0(11)

C(4)-N(1)-C(1')-C(7')

109.9(11)

N(2)-C(2)-C(1')-N(1)

-149.51(17)

C(3)-C(2)-C(1')-N(1)

-26.4(2)

N(2)-C(2)-C(1')-C(7')

104.0(10)

C(3)-C(2)-C(1')-C(7')

-132.9(10)

C(6')-C(7')-C(1')-N(1)

35.9(18)

C(6')-C(7')-C(1')-C(2)

145.1(15)

C(2)-N(2)-C(8)-O(1)

3.9(3)

C(2)-N(2)-C(8)-C(9)

-176.46(18)
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Symmetry transformations used to generate equivalent atoms:
Table A.7: Hydrogen bonds for ()-AcAP [Å and °].
D-H...A

d(D-H)

d(H...A)
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d(D...A)

<(DHA)
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